WO2007118430A1 - A functional composite material with good curative effect and preparation, uses thereof - Google Patents

A functional composite material with good curative effect and preparation, uses thereof Download PDF

Info

Publication number
WO2007118430A1
WO2007118430A1 PCT/CN2007/001244 CN2007001244W WO2007118430A1 WO 2007118430 A1 WO2007118430 A1 WO 2007118430A1 CN 2007001244 W CN2007001244 W CN 2007001244W WO 2007118430 A1 WO2007118430 A1 WO 2007118430A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
cases
functional composite
tourmaline
powder
Prior art date
Application number
PCT/CN2007/001244
Other languages
French (fr)
Chinese (zh)
Inventor
Mengjun Yang
Zhilong Xu
Ping Li
Zhe Yang
Original Assignee
Mengjun Yang
Zhilong Xu
Ping Li
Zhe Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mengjun Yang, Zhilong Xu, Ping Li, Zhe Yang filed Critical Mengjun Yang
Publication of WO2007118430A1 publication Critical patent/WO2007118430A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared
    • A61N2005/066Radiation therapy using light characterised by the wavelength of light used infrared far infrared

Definitions

  • the invention belongs to the field of powder products and relates to a medical functional composite material with high curative effect. More specifically, the invention relates to a composite material comprising a tourmaline and/or crystalline infrared material. The invention also relates to methods of making and using the materials.
  • Chronic diseases currently account for the largest number of patients worldwide (more than 70% of adults suffer from varying degrees of chronic disease), with the highest proportion of deaths (World Health Organization warns that by 2015, the global number of chronically ill deaths will reach 4 100 million people), the highest medical expenses (accounting for nearly 60% of the total global medical expenses).
  • chronic diseases often require long-term medical treatment or even lifelong treatment, and the harm of drugs and side effects is also very large.
  • the number of people who die from adverse drug reactions in China every year reaches Nearly 200,000 people, each year due to adverse drug reactions, up to 30% of inpatients (People's Health Prevention and Treatment, People's Health Publishing House, 2002 edition), drug injury, drug abuse, drug dependence has become a global Outstanding issues. Due to the high incidence and refractory of chronic diseases, the toxic side effects of drugs are becoming more and more prominent. The ideal technology for non-drug and non-surgical treatment of chronic diseases is very scarce.
  • Tourmaline materials have been successfully used in the radio industry and ceramics, clothing, tobacco and other industries.
  • the Japanese scientific community uses tourmaline for environmental protection, household chemicals, plastics, building decoration, automotive, defense, coatings, soil improvement, water treatment, Purify the air, shield electromagnetic radiation, cosmetics, health products, health clothing and other aspects.
  • the existing technical inventions of tourmaline composites are limited to general auxiliary health care functions, and the health care functions are relatively simple, and the health care effects are not satisfactory. It has not been invented by the specific agitation of biological waves on the surface of sensitive surfaces (acupoints) to obtain the "brain agitation effect".
  • the tourmaline composite functional materials and techniques that have direct therapeutic effects on chronic diseases have not been invented.
  • the object of the present invention is to provide a high-efficiency functional composite material having a therapeutic effect on chronic diseases, which can be manufactured into powder, hard solid and soft solids and other solid preparations, and can effectively treat various chronic diseases and is widely used. In the field of health, treatment and rehabilitation of the human body.
  • the high-efficiency functional composite of the present invention is made up of the following weight percentages of raw materials:
  • the tourmaline used in the present invention is a silicate natural mineral having a permanent electrode and rich in more than 10 kinds of important mineral elements, and is produced in Xinjiang, Yunnan, and other places in China and abroad. Available for sale.
  • the tourmaline according to the present invention is one or more selected from the group consisting of tourmaline, tourmaline, iron tourmaline, and tourmaline.
  • the crystal infrared material of the present invention is capable of transmitting infrared rays and having different transmittances for different wavelengths of infrared rays
  • the refractive index and dispersion oxide crystal material is one or more selected from the group consisting of oxide crystals such as AL 2 O 3 , Si0 2 , MgO, and TiO 2 , and is commercially available from both domestic and foreign markets.
  • oxide crystals such as AL 2 O 3 , Si0 2 , MgO, and TiO 2
  • the mediated strengthening material of the present invention is a vanillamide-containing alkaloid, and its chemical name is N-(4-hydroxy-3-methoxybenzyl)-8-methylindole-trans-6-enamide.
  • One or more of its homologous analog and derivative compound monomers may be naturally or artificially synthesized, including but not limited to vanillin citrate; sold at home and abroad.
  • the embedding agent according to the present invention is a mixture of paraffin oil, rosin, methyl cellulose or a combination of any two. For conventional chemical materials.
  • the preparation method of the high-efficiency functional composite powder material of the present invention is -
  • the tourmaline and / or crystal infrared materials are superfinely pulverized by ordinary pulverization and high-speed ball milling.
  • the particle size of tourmaline ultrafine pulverization is ⁇ 5 ⁇ m, and the ultrafine pulverization diameter of crystal infrared material is ⁇ 500 ⁇ m.
  • the raw materials are compounded, added to the mixing machine, and stirred and mixed sufficiently.
  • the preparation method of the high-efficiency functional composite soft solid material of the invention is:
  • High-efficiency functional composite soft solid materials are prepared with high-efficiency functional composite powder 20%-60%, soft solid matrix material 40%-80%, wherein the soft solid matrix material is natural or synthetic rubber powder or other soft solid. One or more of the matrix materials.
  • the high-efficiency functional composite powder and the soft solid matrix material are thoroughly mixed by conventional techniques, and then formed into a high-efficiency functional composite soft solid material.
  • the preparation method of the high-efficiency functional composite hard solid material of the present invention is -
  • the high-efficiency functional composite powder prepared according to the second aspect of the present invention is further added with a binder of 1-5%, wherein the binder is linseed oil, castor oil, stearic acid, polyvinyl chloride, rosin Any one or a combination of two.
  • the prepared raw materials are added to the mixer and then thoroughly mixed.
  • the high-efficiency functional composite (powder, soft solid, hard solid) material prepared by the invention can be used in the fields of human health care, treatment and rehabilitation, and is used as a passive medical device and other medical materials as well as textile materials, daily necessities, etc.
  • the passive medical device device referred to in the present invention refers to a medical device and equipment that does not require an external power source or a magnetic source.
  • Polar ore tourmaline has spontaneous electrodes, permanent electrodes and electrostatic field phenomena and bioelectrical properties, which can cause bioelectrical effects of the human body.
  • Crystal infrared materials are capable of transmitting infrared light and have different transmittances, refractive indices and dispersions for different wavelengths of infrared light. It is a light functional material. Infrared materials can be combined with tourmaline to emit high emissivity infrared rays, which can cause a series of physiological effects of the human body.
  • the mediated augmentation material capsaicin alkaloid activates the cell potential of the human body surface, and activates the membrane potential of the tissue cells in a resting state and the action potential generated by the tissue cells during excitement.
  • the invention ultrafines the tourmaline and/or crystal infrared material to the nanometer or sub-nano grain size, and the ultrafine particles and the molecules of the mediated strengthening material are mixed, and are embedded in each other by the physical technique of the invention, the material original Some characteristics, the new characteristics of the particles after ultrafine nanocrystallization and the conjugation after embedding and recombination, enable the material of the present invention to produce a node-like agitation effect on the human body surface of the human body.
  • the brain is a three-dimensional whole body, and the nervous system is the dominant system of the human body's overall system.
  • Bioelectricity is the spark of human life, which determines the life and death of the human body.
  • the nervous system transmits and feeds information and energy to the human body through a complex network.
  • the smallest structural unit of the nervous system is the neuron (the nerve cell), which contains hundreds of billions of neurons in the body and continues to produce such cells in the future.
  • Each neuron has a cell body that contains the genetic material of the cell; another dendrite, a branch of the cell body that is dendritic to receive information; and an axon, a slender branch of the cell body, The nerve impulse used to conduct the cell body.
  • a single neuron does not have a clear division of tasks, just as a carrier to convey information through current.
  • a neuron has thousands of dendrites that are associated with other neurons to form the body's bioelectrical network. The neurons are very close to each other but not in contact; the gap between each neuron is called a synapse. There are 100 trillion of these synapses on each of us.
  • the human body is sick, the first is the obstacle in this dominant system, which is embodied in some obstacles in the bioelectric network, and forms sensitive or sensitive points on the human body surface.
  • the functional material of the present invention through the agitation of a specific bioelectric network node generated by the invention, imparts extremely fine adjustment to a human body surface (skin or mucous membrane) node or a sensitive point (acupoint) neuron, affecting certain chemicals of the nervous system, capable of Through the synapse of neurons, a certain axon of a neuron in a bioelectrical network is linked to the dendrites of another neuron, and this resistance is removed, causing potential activity on the brain due to its obstruction. Including voltage, speed, rhythm, and synchrony, the influence factors are eliminated, and a "skin brain agitation effect" is realized, so that the disease can be effectively treated and the human body can be recovered.
  • the functional material of the present invention is used as a medical device or a medical device material to form various medical therapeutic devices and health care devices, and the invention has at least the following six distinct advantages.
  • the treatment is safe.
  • the raw material used in the present invention is a substance which has been proven to be harmless to the human body in the prior art.
  • the functional material of the invention is made into a medical device or a device for treating various chronic diseases, and is a surface treatment of the human body, does not enter the human body, does not cause toxic and side effects to the human body, and can effectively overcome the chronic disease drug in the treatment of chronic diseases which can replace the drug treatment. This worldwide problem of treating toxic side effects.
  • the medical device and the device made of the functional material of the invention utilize the special properties of the material, It can be used without electricity, no magnetism, no radioactivity, no power supply or other energy source, no electrical components, no damage, no maintenance, and simple operation. It can realize complex treatment principle and simple repeat operation. It solves the problem that the prior art therapeutic instruments need to be active, difficult to maintain and difficult to operate.
  • the medical device and equipment made of the functional material of the invention can effectively treat 1-2 million times (1 hour for each treatment), and if each person (or family) uses the treatment twice a day, the service life can reach more than 10 years. .
  • the functional materials of the present invention have low production costs and, at the same time, have a long service life, and therefore, the cost per treatment is more than ordinary. If the cost of production and the number of uses are calculated, the cost per treatment is extremely low. This is very beneficial to reduce the high cost of existing drugs for the treatment of chronic diseases and to curb the increase in medical expenses.
  • the functional materials of the invention make therapeutic medical devices and equipments, and because of the novel and unique mechanism of action, the invention can be applied to the rehabilitation treatment of various chronic diseases of non-infective and non-nutritional.
  • the functional material of the invention makes a therapeutic device for treating chronic diseases, and the curative effect is stable and reliable.
  • a hard solid functional tablet made by the present invention is used to treat brain fatigue effects of students.
  • the subjects were 120 students with the same physical health status and the third-year university students aged 21-22. 60 male and female girls. Boys weigh 55-65Kg and height 170-180cm; girls weigh 50-55Kg and height 160-167cm.
  • the basic pulse of the subject is between 65-70 beats/sec.
  • Treatment method The hard solid functional tablet made by the invention is used, and the sensitive point is selected, and the acupuncture position is: the midpoint of the forehead, and the 0.5 inch at the Yintang.
  • the functional piece is placed on the fixed acupoint, and the ribbon is tied around the head for one week.
  • One treatment for one hour, two times a day, and one for each afternoon, can be treated in class or study.
  • test tools using the Chinese Wechsler Children's Intelligence Scale, all subjects were tested twice before and after. Intervals: The treatment group was 30-52 days with an average of 38 days; the control group was 30-60 days with an average of 40 days. The test results were uniformly scored.
  • Heroin was banned in hospital for 72-hour drug users, opioid agonists were used to replace detoxification, and withdrawal symptoms were observed when the dose was decreased. Diagnostic criteria are based on DSM- ⁇ -R, which meets the criteria for opioid withdrawal syndrome and excludes any other physical or mental or mental disorders.
  • Another 38 patients who underwent drug control for withdrawal symptoms at the same time were selected as the control group.
  • the course of drug abuse 12 cases in 1 year, 20 cases in 1-2 years, 6 cases in 2 years or more; Drug abuse: 2 cases of cigarette smoking, 25 cases of scalding, 11 cases of injection, the average daily dose of drug in the last week was 1. 30g.
  • the treatment group and the control group were basically the same.
  • the functional body produced by the invention can replace traditional acupuncture, massage and modern electrotherapy, magnetic therapy, infrared therapy and chemical therapy.
  • Sensitive point selection prescription Group 1: Milk (two sides), Yintang, Sun (two sides), Zhongmu, Zusanli (bilateral), Shenmen (two sides)
  • Group 2 Neiguan (bilateral), Waiguan (bilateral), Hegu (bilateral), Laogong (bilateral), Sanyinjiao (bilateral)
  • Treatment time Week 1: The two groups of points are used alternately in the morning and afternoon, twice daily.
  • Week 2 The two groups of acupuncture points are used alternately once a day.
  • Week 3 Choose one of the two groups of points, once every other day.
  • the withdrawal symptom scale has 23 observation indicators, the score of each indicator is: 0 points asymptomatic; 1 point symptoms are mild or occasional, No treatment is required; 2 points are obvious, requiring treatment but can be tolerated; 3 points are obvious, requiring treatment, unbearable. After the treatment, the onset time was observed and recorded every 5 minutes, and the aging was recorded.
  • Recent control drug-seeking behavior, craving for disappearance, symptoms are basically disappeared or mild; withdrawal syndrome scores are less than 8 points. Better: Searching for behavior, hunger is significantly weakened, symptoms are significantly reduced; withdrawal symptoms are between 8-15 points. Invalid: Symptom Before the symptoms are treated, the withdrawal symptoms score is 15 points or more; stealing or switching to other methods to control the addict.
  • Heroin withdrawal syndrome has different clinical manifestations, but at least 4-5 of Table 2 can be diagnosed.
  • the post-treatment scores are shown in Table 2.
  • Control group 38 20 (52.63) 16 (42.11) 2 (5.26) 94.74 Table 2 Points of withdrawal symptoms before and after treatment (X soil S)
  • Headache 20 2.00 ⁇ 0.28 0.75 ⁇ 0.54
  • Heart rate is faster 35 1.65 ⁇ 5.24 78.40 ⁇ 3.39
  • the onset time was 15-25 minutes, with an average of 5.90 ⁇ 4.85 points; the drug DHE group was effective, with an average of 10.75.
  • Drug DHZ is an opioid receptor agonist, which has a strong substitute for heroin.
  • BUP is an opioid receptor semi-agonist and semi-antagonist, which can partially replace heroin.
  • the former has obvious physical and mental dependence and should not be used for a long time.
  • the latter has a small adverse reaction, but it also has the disadvantage of addiction, which limits the use time of drug addiction.
  • the treatment with the functional body of the invention belongs to the surface effect therapy of nano materials, has no adverse reaction, is safe, and is not addictive to repeated treatment.
  • Table 3 shows that the onset time of the treatment group was 15 points, accounting for 38.63%, the fastest 3 cases were effective for 5 minutes, and the slowest was 25 minutes, which was related to individual differences. That is to say, the meridian sensitivity of the bioelectric network is different, so the effect is different.
  • DHZ works quickly, mostly in 10 minutes, accounting for 75.0°/.
  • BUP has a slower effect, which is mostly in 30 minutes, accounting for 55.56%. From this point of view: The functional body of the invention has less effective time than DHZ, but faster than BUP.
  • Kidney yin deficiency plus Taixi, Shenshu; qi and blood deficiency, plus sputum, spleen; turbidity in the middle of the block, Fengshu, spleen; Fengyang on the discretion plus Tai Chong, wind pool.
  • Operation Use the special function of vertigo to care for the main point and add points according to the syndrome differentiation.
  • the functional body treatment surface At the time of treatment, after selecting the acupoints, stick the functional body treatment surface to the acupuncture points, fix it with a breathable tape, and take it off after 1 hour of treatment.
  • Acupoints for sensitive points Shuigou, Neiguan, Laogong, Quchi, and Venezuela.
  • Half-length person with shoulders Hegu, Waiguan, Huanqiu, Yanglingquan, Zusanli, Xiexi, Kunlun, Taichong; mouth and eye slanting plus warehouse or cheek car, Hegu, inner court, Chengqi, Yangbai, ⁇ Bamboo, Kunlun, old-age care; language disadvantaged plus Lianquan, Tongli, Yamen, Fengfu, Tiantu, Sanyinjiao.
  • the functional body After selecting the sensitive acupuncture points, the functional body is attached to the selected sensitive points, and fixed with a breathable tape or a special elastic band. Each time for 1 hour, each time with 4-5 points, the acupuncture points of each group are used alternately. . 1 time, 1 time, 10 times for 1 course of treatment; 1 day after the end of the course of treatment, rest for 2 days and then 1 course of treatment.
  • the total effective rate is 90%. Among them, at least 1 course of treatment and up to 9 courses of treatment. Average treatment 3. 8 courses of treatment.
  • liver qi stagnation type dry or not dry stool, difficult to resolve bowel movements, less than 3 times a week, even 1 week 1 solution, abdominal pain and even two threats, mouth pain, dizziness, symptoms with mood fluctuations, tongue Light, thin white fur, weak and weak.
  • liver qi stagnation type in 21 cases, accounting for 42%; heart and spleen deficiency type in 29 cases, accounting for 58%.
  • the basic side is bilateral large intestine Yu, Zusanli and Zhongyu. Liver qi stagnation type plus bilateral Yanglingquan, inter-line, heart and spleen deficiency type plus bilateral Sanyinjiao and Guanyuan. Select the functional body during treatment, apply the functional body to the selected sensitive point for 1 hour, use elastic With or with a breathable tape. 1 course every 10 days, once a day; 2 courses per treatment, 2 days in the middle, the observation period is two months.
  • Treatment methods 1 sensitive points: Dazhui, Neiguan, Jiangyan, Taichong, Hegu, Fengchi (both sides), Ganshu, Baihui.
  • the functional body When treating with the functional body made by the invention, the functional body is attached to the acupuncture points of the selected sensitive points, and is fixed by elastic band or gas permeable tape, and each treatment is for 1 hour, 4-5 times for each use point, and the acupuncture points of each group are alternated. Use, once a day, every 10 times for a course of treatment. During this period, you must quit smoking and alcohol, be cautious, keep your urine and urine open, and stop using any treatment.
  • the functional body made by the invention treats 50 cases of coronary heart disease
  • TCM The clinical classification of TCM was 13 cases of blood stasis type, 11 cases of turbidity type, 8 cases of qi stagnation type, 7 cases of qi deficiency type, 11 cases of qi and yin deficiency type, and 5 cases of heart yang deficiency type.
  • Sensitive points take acupuncture points to the specific acupoints of the functional body, and the heart and the pericardium are mainly based on Yu's acupoints.
  • Pericardium through the acupoints group 1, giant scorpion, Xinshu, Yushu, Neiguan, Gongsun, yin; the second group, Suizhong, Yuyin Yu, Sanyinjiao, Tuen Mun.
  • the two groups are used alternately, turbidity plus Taiyuan: deficient cold plus sputum or sputum.
  • the functional body When using functional body therapy, the functional body can be applied to the selected sensitive points for 1 hour, once a day, 10 times for a course of treatment, and generally observed for 3 courses.
  • Efficacy criteria 1. The standard of angina pectoris and electrocardiogram was based on the National Standards for Assessment of Angina Pectoris and Electrocardiogram in 1979. 2. The main symptom efficacy criteria (including chest pain, palpitations, shortness of breath 3): markedly the symptoms disappeared completely or disappeared; improved as symptomatic procedures were significantly reduced; invalid symptoms were basically the same as before treatment; aggravated symptoms worsened than before treatment . 3. The standard of blood lipids is based on the standards set by the Shanghai Compound Danshen Collaborative Group in 1974.
  • total cholesterol was 30 cases, 23 cases were effective; triglyceride was high in 20 cases, 10 cases were effective.
  • ECG changes Where there is ST-T change, V wave changes, atrial fibrillation, sick sinus, frequent ventricular premature beats, frequent premature atrial contractions, complete right bundle branch conduction and conduction resistance are improved.
  • Sensitive points are taken from Baihui, Sishencong, Dazhui and Guanyuan. After fully functionalizing the functional body surface and the acupoint skin surface with the functional body prepared by the invention, the functional body is attached to the selected sensitive point, and then the elastic band or the gas permeable adhesive cloth is used for fixing. Set.
  • the acupuncture points on the head are fixed with a synergistic membrane. Each treatment for 1 hour, once a day, 10 times for a course of treatment, general treatment for 2-3 months. Rest 2 days between each course of treatment. Patients can continue to use antihypertensive, lipid-lowering, hypoglycemic, and anti-platelet aggregation drugs during treatment.
  • Efficacy criteria Basic recovery: Symptoms disappear, self-care, can carry out normal social interaction activities; Significant effect: Symptoms improve, but slow response, mental and personality disorders, life can not take care of themselves; Ineffective: No change before and after treatment.
  • the results were basically cured in 7 cases, markedly effective in 33 cases, effective in 26 cases, and ineffective in 10 cases. Of the 19 patients with a course of ⁇ 1 year, 6 were basically cured, 9 were markedly effective; those with ineffective treatment were all > 3 years. The effective rate is 86%.
  • Diagnosis basis 1 history of acute inflammatory bowel disease or repeated episodes; 2 onset, diarrhea, abdominal pain, etc., patients may have chronic malnutrition, physical examination may have abdominal tenderness, white blood cells, cells and a small number of pus cells can be seen routinely. 3 X-ray barium examination and colonoscopy to exclude other non-specific intestinal inflammation.
  • the upper holes are divided into two groups.
  • the first group Umbilical Thursday, Zhongmu, Tianshu, Guanyuan, Zusanli, Shangjuxu, Hegu, Sanyinjiao; Group 2: spleen, Shenshu, Dachangshu, Zusanli, Shangjuxu, Hegu .
  • the acupuncture points of the two groups are alternately used every day.
  • the functional body of the present invention is used, and it is attached to the acupuncture points of the selected sensitive points, 4-5 acupuncture points each time, and fixed by air-permeable tape, each treatment for 1 hour. 10 times for 1 course of treatment.
  • the acupoints in the prone position are attached to the acupuncture points of the selected sensitive points by the functional body of the present invention, and are fixed by elastic bands or breathable tapes, and each treatment is performed for 1 hour, and the functional body can be removed after the treatment.
  • the above treatment is performed once a day, each time taking 4-5 of the main and matching points, and alternately selecting. A course of treatment every 10 days, rest 3-5 days between treatments.
  • Cure Conscious symptoms disappear, prostatic fluid microscopy is normal; Significant effect: Conscious symptoms disappeared, no more than 3 white blood cells in prostatic fluid at high magnification; Improved: Significantly relieved symptoms, 4-6 of white blood cells in prostatic fluid at high magnification; Invalid: There were no significant changes in the symptoms and prostatic fluid tests.
  • the functional body made by the invention treats 36 cases of trigeminal neuralgia
  • the group treated a total of 56 patients, including 20 males and 36 females; the oldest 78 years old, the youngest 35 years old; the first pain 5 cases, the second pain 15 cases, the third pain 16 cases; the composite type 20 cases
  • the course of disease was as short as 1 month and the longest was more than 10 years; 48 cases were primary and 8 cases were secondary.
  • Sensitive points for acupoints the first pain is taken from the waist of the fish, and the lower part is mainly used. It can be used with points such as Yangbai, Shangxing, Hegu, and Inner Court. Second, three pains take four white, Shimonoseki, the warehouse, the folder, the Hegu, the inner court and so on.
  • the acupuncture points on the head and face are taken from the affected side;
  • the functional body made by the invention is applied to the sensitive point, once a day, 10 times for a course of treatment, rest for 3-5 days, and the next course of treatment can be continued.
  • Treatment results 38 patients in this group had oral carbamazepine tablets before treatment, and stopped taking the drug after treatment for a period of time.
  • the functional body prepared by the present invention was not treated during the treatment. 18 patients who did not take the drug Functional body treatment with carbamazepine tablets 0. lg, 2 times a day.
  • the functional body prepared by the present invention is treated at least 6 times and at most 20 times. 42 cases were cured clinically, accounting for 75%; 9 cases were markedly effective, accounting for 16.1%; 5 cases were improved, accounting for 8.9%; 0 cases were ineffective; the total effective rate was 100%. Among them, 42 cases had no recurrence within 6 months of follow-up, and 11 cases relapsed within 3 - 4 months, but the symptoms were mild. The symptoms disappeared after 5-10 treatments of the functional body of the present invention. Three patients with cholesteatoma were transferred to hospital for treatment after symptom reduction, and no follow-up was performed.
  • Acupoints for sensitive points The main points are Fengchi and Baihui, and according to clinical syndrome differentiation, they are equipped with different acupoints.
  • Exogenous type The headache is caused by the wind, and the pain is more dramatic. It is accompanied by Fengfu, Lie, Waiguan and Hegu.
  • Liver-yang type The head horn is sore, mostly on one side, or even on the dome, with the points of Sishencong, Taichong and Shuiquan.
  • Blood type pain such as cone thorn, long-term unhealed, with Sanyinjiao, Ashi points.
  • the functional body made by the invention treats 50 cases of gastric and duodenal ulcer
  • Case selection The selected 80 hospitalized patients were in accordance with the diagnostic criteria for gastric and duodenal ulcers. They were randomly divided into two groups, 50 patients in the treatment group, including 35 males and 15 females; aged 24-62 years, mean (35. 5 ⁇ 11. 3) years; disease duration 0. 5- 20 years, average (6. 4 ⁇ 2. 8) years; 19 cases of gastric ulcer, 26 cases of duodenal ulcer, 5 cases of compound ulcer; 44 cases of negative occult blood test. 4 cases were weakly positive and 2 cases were positive. 30 patients in the control group, including 18 males and 12 females; aged 20-68 years, mean (34.4 ⁇ 12. 4) years; duration of disease 4 months - 18 years, average (6.5 ⁇ 3.
  • treatment group sensitive points acupoints the first group to take Zusanli, Neiguan, Gongsun; the second group to take Zhongyu, spleen, stomach Yu. Stomach pain is even more plus Liangqiu, stomach cold is added to the lower jaw, abdominal distension is even more Tianshu, acid reflux is too rushing, then Secret plus sulcus, insomnia plus the door, weak and refueling the sea.
  • the above two groups of acupoints are used alternately, once a day, using the functional body made by the present invention, and sticking it on the selected sensitive point, and fixing it with air-permeable tape for 1 hour and 10 times for one course of treatment. After 2 months, the gastroscope was reviewed.
  • Acupuncture points in the control group The acupoints are the same as above, but the common acupuncture needles are used to replenish the diarrhea. Ulcer bleeding (mild) can aid medication.
  • Acupoints for sensitive points divided into four groups: the first group of points: Yintang, Yongquan, Hegu; The second group of points: Yintang, Fengchi, Zhongli; The third group of points: Neiguan, hurricane, sun, full headache plus Around the hair circle; the fourth group of wind pools, Neiguan, the sun, the rate valley.
  • the functional body prepared by the invention is attached to the acupoint surface of the sensitive point, and fixed with an elastic band or a breathable adhesive tape.
  • Each treatment is for 1 hour, 10 days is a course of treatment, and the treatment rests for 2 days, and the therapeutic effect is evaluated after 2 courses of treatment.
  • Clinical cure After treatment, the pain disappears, return to normal work and life, no recurrence after 6 months of follow-up; markedly effective: After treatment, the pain disappears, return to normal work and life, relapse within half a year; Effective: After treatment, winter pain relieves, tired, When the anger is aggravated, there is a recurrence; Ineffective: The pain is not relieved after treatment.
  • the composition (weight percentage) of the prepared high-efficiency functional composite is: tourmaline ultrafine powder 56%, crystalline infrared material ultrafine powder 40% (including Si0 2 crystal 20%, Si0 2 crystal content >90%, MgO crystal 10%) , MgO crystal content >90%, AL 2 0 3 crystal 10%, AL 2 0 3 crystal content >90%), mediated strengthening material 2% (for synthesis of succinic acid vanillamide, 70% content), embedded 2% (including paraffin oil 1%, rosin 1%).
  • the tourmaline ultrafine powder has a particle size of 100 nm
  • the crystalline infrared material ultrafine powder has a particle size of 500 nm.
  • tourmaline ultrafine powder is purchased from the market for high quality tourmaline ore, which is subjected to ordinary pulverization, followed by high speed ball milling and subsequent heat treatment.
  • the high-speed ball milling time is 80 hours
  • the heat treatment temperature is 900 ° C
  • the holding time is 2 hours.
  • the crystal infrared material is purchased from the market through ordinary pulverized powder raw materials, subjected to idle ball milling, and then heat treated.
  • the high-speed ball milling time is 50 hours
  • the heat treatment temperature is 800 ° C
  • the holding time is 2 hours.
  • the above ingredients are put into the V-type mixing mixer, fully stirred, mixed and fully hooked, placed in a sealed constant temperature drying oven, and heated, the heating temperature is 140 ° C, and the holding time is 1 day, ie It is a high-efficiency functional composite powder material for human health care, rehabilitation, treatment and quality of life.
  • the intensive enhancer material is 2%, which is a weaker strength, and is used for acupuncture treatments sensitive to the human body, such as Shenque (umbilical) treatment or acupuncture treatment of head and neck.
  • High efficacy functional composition formulated composite material (by weight) of: 55% ultrafine tourmaline, 40% crystalline superfine infrared materials (including crystals Si0 2 20%, Si0 2 crystal content> 90%, MgO 10% crystalline , MgO crystal content > 90%, AL 2 0 3 crystal 10%, AL 2 0 3 crystal content > 90%,), mediated strengthening material 3% (for the synthesis of n-antimonic acid vanillamide, 70%), package
  • the embedding agent is 2.0% (including paraffin oil 1%, rosin 1.0%), wherein the tourmaline ultrafine powder has a particle size of 90 nm, and the crystalline infrared material ultrafine powder has a particle size of 450 nm.
  • tourmaline ultrafine powder is a tourmaline ore originally purchased from the market, which is firstly pulverized, then added to a high speed ball mill ball mill, followed by heat treatment.
  • the high-speed ball milling time is 80 hours
  • the heat treatment temperature is 900'C
  • the heat preservation time is 2 hours.
  • the crystal infrared material is a common powder raw material purchased from the market, and is also added to a high-speed ball mill ball mill, followed by heat treatment.
  • the ball milling time was 50 hours
  • the heat treatment temperature was 800 ° C
  • the holding time was 2 hours.
  • the above ingredients are put into a V-type mixing mixer, mixed and stirred, and then fully mixed and hooked, placed in a sealed constant temperature drying oven, and subjected to heating treatment at a heating temperature of 150 ° C. , holding time 2 days.
  • the powder prepared by the above process was placed in an octagonal mold, and pressed into an octagonal sheet shape on a press having a diameter of 3 cm, a thickness of 0.3 cm, and a pressing force of 24 MPa.
  • the prepared sheet-like hard solid is a high-efficiency functional composite hard solid material, which can be used for rehabilitation equipment and equipment for human health and chronic diseases.
  • the high-efficiency functional composite hard solid material prepared in this Example 2 can be used as a hard solid functional tablet used in the above clinical effects.
  • the hard solid functional sheet used in the above clinical effects may be in the form of an octagonal sheet prepared as described above, having a diameter of 3 cm and a thickness of 0.3 cm.
  • the 3% of the reinforcing agent material is a slightly stronger strength, and is used for the general sensitive acupoint treatment of the human body, such as body acupoint treatment.
  • the composition (weight percentage) of the prepared sputum therapeutic functional composite is: tourmaline ultrafine powder 52%, crystalline infrared material ultrafine powder 40% (where SiO 2 crystal 20%, Si0 2 crystal content > 90 ° /., MgO crystal 10%, MgO crystal content >90%, AL 2 0 3 crystal 10%, AL 2 0 3 crystal content >90%), mediated strengthening material 5% (for the synthesis of n-carboxamide, 70%)
  • the embedding agent is 3% (including paraffin oil 1.5%, rosin 1.5%).
  • the tourmaline ultrafine powder has a particle size of 80 nm, and the crystalline infrared material ultrafine powder has a particle size of 500 nm.
  • tourmaline ultrafine powder is purchased from the market for tourmaline ore, which is subjected to ordinary pulverization, and then into a high-speed ball mill for ball milling, followed by heat treatment.
  • the ball milling time is 80 hours
  • the heat treatment temperature is 900 ° C
  • the holding time is 2 hours.
  • the crystal infrared material is purchased from the market, then subjected to high-speed ball milling, followed by heat treatment.
  • the high-speed ball milling time is 50 hours
  • the heat treatment temperature is 800V
  • the holding time is 2 hours.
  • the above ingredients are put into the mixer, fully stirred, and mixed thoroughly, and then placed in a sealed constant temperature drying box for heating treatment, the heating temperature is 150 ° C, and the holding time is 2 days.
  • the compounded rubber mud is a high-efficiency functional composite soft solid material, which can be used for human health care and chronic diseases, rehabilitation equipment and equipment, and beauty and body to improve the quality of life.
  • the 5% of the reinforcing agent material is a strong intensity, and is used for acupoint treatment of the human body, such as limb acupoint treatment.
  • the high-efficiency functional composite soft solid material prepared in this Example 3 can be used as the functional body used in the above clinical effects.
  • the functional body used in the above clinical effects is a circular sheet having a diameter of 3 cm and a thickness of 0.2 to 0.3 cm.
  • the composition (weight percentage) of the formulated high-efficiency functional composite is 60% of tourmaline ultrafine powder, and 35% of crystalline infrared material ultrafine powder (including AL 2 0 3 20%, content > 90%, MgO 15%, content > 90) %; ), mediated enhancer 0, 5% (for synthesizing n-citric acid vanillamide, 70%), embedding agent 4.5% (including paraffin oil 1%, rosin 1%, methyl cellulose 2) .5%).
  • the average particle size of the tourmaline ultrafine powder is 125 nm, and the ultrafine particle size of the crystalline infrared material is 500 nm on average.
  • tourmaline ultrafine powder is purchased from the market for high quality tourmaline ore, which is subjected to ordinary pulverization, followed by high speed ball milling and subsequent heat treatment.
  • the high-speed ball milling time is 80 hours, the heat treatment temperature is 950 ° C, and the holding time is 2 hours.
  • the crystal infrared material is purchased from the market through ordinary pulverized powder raw materials, subjected to high speed ball milling, and then heat treated.
  • the high-speed ball milling time is 56 hours, the heat treatment temperature is 850 ° C, and the holding time is 2 hours.
  • the above ingredients are put into a V-type mixing mixer, mixed and stirred, and fully mixed and hooked, placed in a sealed constant temperature drying oven, and subjected to heating treatment, and the heating temperature is 15 (TC, holding time is 1 day. Become a high-efficiency composite functional powder material.
  • the weight percentage 50% by weight of the powder material of the above-mentioned processed ⁇ therapeutic functional composite, 50% by weight of soft solid matrix material (liquid resin), placed in the homogenizer, thoroughly stirred and mixed, and then vacuum pump Into the circle
  • the film mold is heated and solidified (curing temperature is 180 °C), which becomes a high-effect functional material soft film, which is used for the treatment of special sensitive acupoints such as milk in the human body, to recover diseases and improve the quality of life.
  • composition (weight percentage) of the formulated high-efficiency functional composite is 40% of tourmaline ultrafine powder, 30% of crystalline infrared material ultrafine powder (AL 2 0 3 30%, content > 90%), and 28% of intensive enhancer ( For the synthesis of n-antimonic acid vanillamide, 70%), embedding agent 2% (including paraffin oil 1%, rosin 1%), wherein the tourmaline ultrafine powder has an average particle size of 120 nm, AL 2 0 3 micropowder average The particle size is 1 micron.
  • tourmaline ultrafine powder is a tourmaline ore originally purchased from the market, which is firstly pulverized and then put into a high-speed ball mill ball mill, followed by heat treatment.
  • the high-speed ball milling time is 80 hours
  • the heat treatment temperature is 950 ⁇
  • the holding time is 2 hours.
  • AL 2 0 3 is a powder purchased from the market. The powder has an average particle size of about 1 micrometer and is heat-treated at a heat treatment temperature of 800 ° C for 2 hours.
  • the above processed powder, medium-intensifying agent and embedding agent are put into a V-type mixing mixer, mixed and stirred, and thoroughly mixed, and placed in a sealed constant temperature drying oven for heating treatment and heating.
  • the temperature is 150 ⁇ and the holding time is 2 days. It becomes a high-efficiency composite functional powder material.
  • weight percentage 50 parts by weight of the above-mentioned processed high-efficiency functional composite powder material, and 50% by weight of soft solid matrix material (liquid resin), placed in a homogenizer, thoroughly stirred and mixed, and then vacuum pump Pumped into a circular die, heated and cured (curing temperature is 180 °C), it becomes a super-soft functional film for high-efficiency functional materials, which is used for treatment of special acupoints such as Yongquan acupoints in human foot, rehabilitation Disease and improve the quality of life.
  • soft solid matrix material liquid resin
  • the therapeutic effect functional composite of the present invention may be a powder material, a hard solid material or a soft solid material, and can be used for improving the quality of life of human health care and chronic disease rehabilitation treatment equipment and equipment, and beauty and body. It is used to treat students' brain fatigue, treat children with learning difficulties, control heroin dependence withdrawal symptoms, treat dizziness, treat stroke sequelae, treat constipation irritable bowel syndrome, treat hypertension, treat coronary heart disease, treat senile dementia, treat Chronic enteritis, treatment of chronic prostatitis, treatment of trigeminal neuralgia, treatment of general headache, treatment of stomach, duodenal ulcer, etc., and the effect is remarkable.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A functional composite material with good curative effect can be made of 66-96wt% tourmaline superfines and/or crystal infrared material superfines, 0.01-30wt% media reinforcing material and 1-5wt% embedding agent, and one or more soft solid substrate material or adhesive may be further incorporated into the powder of the composite to obtain a composite in form of soft or hard solid. The composite material can be produced into various passive medical apparatuses to effectively cure various non-infectious and non-nutritional diseases by treating at sensitive spots of the body surface instead of acupuncture, medication and active mechanotherapy, so it can be applied for health care, therapy and healing of people.

Description

一种高疗效功能复合材料及其制备方法与用途 技术领域  High-efficiency functional composite material, preparation method and use thereof
本发明属于粉末制品领域, 涉及一种具有较高疗效的医疗功能复合材料。 更具体地说, 本发明涉及一种含有电气石和 /或晶体红外材料的复合材料。 本发明还涉及该材料的制备方 法和用途。  The invention belongs to the field of powder products and relates to a medical functional composite material with high curative effect. More specifically, the invention relates to a composite material comprising a tourmaline and/or crystalline infrared material. The invention also relates to methods of making and using the materials.
背景技术 Background technique
世界医学已由第一次卫生革命开始进入第二次卫生革命。 已有的医学技术对感染性疾 病、 营养性疾病具有确切治疗手段。 但是更多感染性疾病、 营养性疾病以外的各种慢性疾 病却缺乏理想治疗技术。  World medicine has entered the second health revolution from the first health revolution. Existing medical technology has definitive treatments for infectious diseases and nutritional diseases. However, many chronic diseases other than infectious diseases and nutritional diseases lack ideal therapeutic techniques.
慢性疾病目前在全球患病人数最多 (成年人中 70%以上的人患有不同程度的慢性疾 病), 死亡率比例最大 (世界卫生组织警告, 到 2015 年, 全球慢性患病死亡人数将达到 4 亿人), 医疗费用最高(占全球医疗费用总比例近 60%) .而且, 慢性病往往需要长期药物治 疗甚至终身治疗, 药物毒副 作用的危害也非常大, 例如中国每年死于药物不良反应人数达 到近 20万人, 每年因药物不良反应而住院治疗者高达住院病人的 30% (《药害临床防治大 全》人民卫生出版社, 2002年版), 药物伤害、 药物滥用、 药物依赖日益成为全球一个十分 突出的问题。 由于慢性病的高发与难治, 药物的毒副作用问题越来越突出, 非药物与非手 术疗法有效治疗慢性病的理想技术十分缺乏。  Chronic diseases currently account for the largest number of patients worldwide (more than 70% of adults suffer from varying degrees of chronic disease), with the highest proportion of deaths (World Health Organization warns that by 2015, the global number of chronically ill deaths will reach 4 100 million people), the highest medical expenses (accounting for nearly 60% of the total global medical expenses). Moreover, chronic diseases often require long-term medical treatment or even lifelong treatment, and the harm of drugs and side effects is also very large. For example, the number of people who die from adverse drug reactions in China every year reaches Nearly 200,000 people, each year due to adverse drug reactions, up to 30% of inpatients (People's Health Prevention and Treatment, People's Health Publishing House, 2002 edition), drug injury, drug abuse, drug dependence has become a global Outstanding issues. Due to the high incidence and refractory of chronic diseases, the toxic side effects of drugs are becoming more and more prominent. The ideal technology for non-drug and non-surgical treatment of chronic diseases is very scarce.
电气石材料已成功用于无线电工业和陶瓷、 衣料、 烟草等行业, 日本科技界将电气石 用于环保、 日用化工、 塑料、 建筑装璜、 汽车、 国防、 涂料、 改良土壤、 水质处理、 净化 空气、 屏蔽电磁幅射、 化妆品、 保健品、 健康衣料等方面。 在健康领域, 电气石复合材料 已有的技术发明均局限于一般辅助保健功能, 保健功能比较单一, 保健效果不理想。 通过 特定激越生物电波对人体体表敏感点 (穴位)表面治疗获得 "皮脑激越效应", 对慢性病具 有直接治疗效果的电气石复合功能材料与技术尚未见有发明。  Tourmaline materials have been successfully used in the radio industry and ceramics, clothing, tobacco and other industries. The Japanese scientific community uses tourmaline for environmental protection, household chemicals, plastics, building decoration, automotive, defense, coatings, soil improvement, water treatment, Purify the air, shield electromagnetic radiation, cosmetics, health products, health clothing and other aspects. In the field of health, the existing technical inventions of tourmaline composites are limited to general auxiliary health care functions, and the health care functions are relatively simple, and the health care effects are not satisfactory. It has not been invented by the specific agitation of biological waves on the surface of sensitive surfaces (acupoints) to obtain the "brain agitation effect". The tourmaline composite functional materials and techniques that have direct therapeutic effects on chronic diseases have not been invented.
发明内容 Summary of the invention
本发明的目的是提供一种对慢性病具有治疗作用的高疗效功能复合材料, 将其制造成 粉体和硬固体及软固体及其他固体制剂等形式, 可以有效治疗多种慢性疾病, 并广泛用于 人体的保健、 治疗和康复领域。  The object of the present invention is to provide a high-efficiency functional composite material having a therapeutic effect on chronic diseases, which can be manufactured into powder, hard solid and soft solids and other solid preparations, and can effectively treat various chronic diseases and is widely used. In the field of health, treatment and rehabilitation of the human body.
本发明技术方案如下:  The technical scheme of the present invention is as follows:
1、 本发明的高疗效功能复合材料由下述重量百分比的原料复合制成:  1. The high-efficiency functional composite of the present invention is made up of the following weight percentages of raw materials:
电气石超微粉和 /或晶体红外材料超微粉 66-96%  Tourmaline ultrafine powder and / or crystal infrared material ultrafine powder 66-96%
介导强化材料 0.01-30%  Mediated strengthening material 0.01-30%
包埋剂 1-5%  Embedding agent 1-5%
本发明所采用的电气石, 即托玛琳(Tumalinge), 是一种具有永久电极与富含 10余种重 要矿物元素的硅酸盐天然矿物, 中国新疆、 云南等地有产, 国内外市场均有售。 本发明所 说的电气石选自铁电气石、 镁电气石、 铁续电气石、 锂电气石等电气石中的一种或几种。  The tourmaline used in the present invention, that is, Tumalinge, is a silicate natural mineral having a permanent electrode and rich in more than 10 kinds of important mineral elements, and is produced in Xinjiang, Yunnan, and other places in China and abroad. Available for sale. The tourmaline according to the present invention is one or more selected from the group consisting of tourmaline, tourmaline, iron tourmaline, and tourmaline.
本发明所说晶体红外材料是为能够透过红外线, 并对不同波长红外线具有不同透过率、 折射率及色散的氧化物晶体材料, 选自 AL203、 Si02、 MgO、 Ti02等氧化物晶体的一种或几 种, 国内外市场均有售。其中, Si02晶体的 Si02 的含量〉90%, MgO晶体的 MgO的含量 >90%; AL203晶体的 A O310%,含量〉 90%, Ti02的 Ti02的含量 >90%。 The crystal infrared material of the present invention is capable of transmitting infrared rays and having different transmittances for different wavelengths of infrared rays, The refractive index and dispersion oxide crystal material is one or more selected from the group consisting of oxide crystals such as AL 2 O 3 , Si0 2 , MgO, and TiO 2 , and is commercially available from both domestic and foreign markets. Wherein, Si0 2 content of the crystals Si0 2> 90%, MgO content of MgO crystals>90%; AO 3 10% AL 2 0 3 crystal, content of> 90%, the content of Ti0 2 to Ti0 2> 90% .
本发明所说的介导强化材料是一种含香草酰胺的生物碱, 化学名为 N- (4-羟基 -3-甲氧 基苄基) -8-甲基壬-反 -6-烯酰胺及其同系类似物和衍生物化合物单体之一种或几种, 可以是 天然提取或人工合成, 包括但不限于壬酸香草酰胺; 国内外市场均有售。  The mediated strengthening material of the present invention is a vanillamide-containing alkaloid, and its chemical name is N-(4-hydroxy-3-methoxybenzyl)-8-methylindole-trans-6-enamide. One or more of its homologous analog and derivative compound monomers may be naturally or artificially synthesized, including but not limited to vanillin citrate; sold at home and abroad.
本发明所说的包埋剂为石蜡油、 松香、 甲基纤维素任一种或任两种之和。 为常规化工 材料。  The embedding agent according to the present invention is a mixture of paraffin oil, rosin, methyl cellulose or a combination of any two. For conventional chemical materials.
2、 本发明的高疗效功能复合粉体材料的制备方法是- 2. The preparation method of the high-efficiency functional composite powder material of the present invention is -
2. 1 将电气石和 /或晶体红外材料分别用普通粉碎、高速球磨超细粉碎, 电气石超微粉碎的 粒径 <5微米, 晶体红外材料超微粉碎粒径〈500微米。 2. 1 The tourmaline and / or crystal infrared materials are superfinely pulverized by ordinary pulverization and high-speed ball milling. The particle size of tourmaline ultrafine pulverization is <5 μm, and the ultrafine pulverization diameter of crystal infrared material is <500 μm.
2. 2将电气石粉和 /或晶体红外材料粉分别进行热处理, 热处理温度 300- 1000°C ,保温时间2. 2 heat treatment of tourmaline powder and / or crystal infrared material powder, heat treatment temperature 300-1000 ° C, holding time
1-5小时。 1-5 hours.
2. 3按本发明重量百分比的配比要求将原料进行配料, 加入混料机中, 使之搅拌混合充分 均勾。  2. 3 According to the ratio of the weight percentage of the present invention, the raw materials are compounded, added to the mixing machine, and stirred and mixed sufficiently.
2. 4将混合充分均匀的原料置于密封的恒温干燥箱进行加温处理, 加温温度为 60-200°C, 保温时间 1-3天。 即成为高疗效功能复合粉体材料。  2. 4 Mix the well-mixed raw materials in a sealed constant temperature drying oven for heating. The heating temperature is 60-200 ° C and the holding time is 1-3 days. That is to become a high-efficiency functional composite powder material.
3、 本发明的高疗效功能复合软固体材料制备方法是:  3. The preparation method of the high-efficiency functional composite soft solid material of the invention is:
3. 1 按本发明技术方案 2. 1, 2. 2, 2. 3, 2. 4, 的制备方法, 完成高疗效功能复合粉体制备。 3. 2用高疗效功能复合粉 20%-60%, 软固体基质材料 40%- 80%的比例配制高疗效功能复合软 固体材料, 其中软固体基质材料为天然或合成橡胶粉或其他软固体基质材料之一种或 几种。  3. 1 According to the technical scheme of the present invention 2. 1, 2. 2, 2. 3, 2. 4, the preparation method, complete the preparation of high-efficiency functional composite powder. 3. 2 High-efficiency functional composite soft solid materials are prepared with high-efficiency functional composite powder 20%-60%, soft solid matrix material 40%-80%, wherein the soft solid matrix material is natural or synthetic rubber powder or other soft solid. One or more of the matrix materials.
3. 3根据软固体基质材料的特性, 采用常规技术将高疗效功能复合粉体与软固体基质材料 充分混合, 进行成形后, 即为高疗效功能复合软固体材料。  3. 3 According to the characteristics of the soft solid matrix material, the high-efficiency functional composite powder and the soft solid matrix material are thoroughly mixed by conventional techniques, and then formed into a high-efficiency functional composite soft solid material.
4、 本发明的高疗效功能复合硬固体材料的制备方法是- 4. The preparation method of the high-efficiency functional composite hard solid material of the present invention is -
4. 1 按本发明技术方案 2. 1, 2. 2制备电气石与晶体红外材料超细粉。 4. 1 According to the technical scheme of the present invention 2. 1, 2. 2 Preparation of ultrafine powder of tourmaline and crystal infrared material.
4. 2按本发明技术方案 1的重量百分比, 分别称取原料。 4. 2 According to the weight percentage of the technical scheme 1 of the present invention, the raw materials are respectively weighed.
4. 3将按本发明技术方案 2制得的高疗效功能复合粉体, 另加入粘结剂 1-5%, 其中粘结剂 为亚麻油、 蓖麻油、 硬脂酸、 聚氯乙烯、 松脂中的任一种或任两种之和。  4. 3 The high-efficiency functional composite powder prepared according to the second aspect of the present invention is further added with a binder of 1-5%, wherein the binder is linseed oil, castor oil, stearic acid, polyvinyl chloride, rosin Any one or a combination of two.
4. 4将按照本发明技术方案 4. 3配备好的原料加入混料机中再充分混合均匀。  4. 4 According to the technical scheme of the present invention, the prepared raw materials are added to the mixer and then thoroughly mixed.
4. 5 将上述混合均勾粉体置于具有一定形状的模具中, 放在压力机上对其施压, 压力为 12 - 30Mpa, 将其压制成形。  4. 5 Place the above-mentioned mixed homogenate powder in a mold with a certain shape, press it on a press, and press it at a pressure of 12 - 30 MPa.
即成高疗效功能复合硬固体材料。  It is a high-efficiency functional composite hard solid material.
5、 本发明所制备的高疗效功能复合(粉体、 软固体、 硬固体)材料, 可用于人类的保健、 治疗与康复领域, 用作无源医疗器械及其他医疗材料以及纺织材 料、 日用品等在人体 体表表面治疗或人体体表敏感点(穴位)治疗,通过内病外治,有效治疗各种非感染性、 非营养性的慢性疾病以及提高生活质量。 替代针灸、 药物治疗与有源器械治疗。 本发明所说的无源医疗器械器材是指不用外加电源、 磁源的医疗器械与器材。 极性矿石电气石存在自发电极、 永久电极与静电场现象和生物电特性, 与人体的生物 电流相匹配可以引起人体的生物电效应。 5. The high-efficiency functional composite (powder, soft solid, hard solid) material prepared by the invention can be used in the fields of human health care, treatment and rehabilitation, and is used as a passive medical device and other medical materials as well as textile materials, daily necessities, etc. Treatment on the surface of human body surface or treatment of sensitive points (acupoints) on the surface of the human body, through internal disease treatment, effectively treating various non-infectious, non-nutritional chronic diseases and improving the quality of life. Alternative to acupuncture, medication and active device therapy. The passive medical device device referred to in the present invention refers to a medical device and equipment that does not require an external power source or a magnetic source. Polar ore tourmaline has spontaneous electrodes, permanent electrodes and electrostatic field phenomena and bioelectrical properties, which can cause bioelectrical effects of the human body.
晶体红外材料能够透过红外线, 并对不同波长红外线具有不同透过率、 折射率及色散。 是一种光功能材料。 红外材料可或与电气石协同发射高发射率的红外线, 可以引起人体一 系列生理效应。  Crystal infrared materials are capable of transmitting infrared light and have different transmittances, refractive indices and dispersions for different wavelengths of infrared light. It is a light functional material. Infrared materials can be combined with tourmaline to emit high emissivity infrared rays, which can cause a series of physiological effects of the human body.
介导强化材料辣椒生物碱对人体体表活的细胞电位有激活作用, 对组织细胞在静止状 态时的膜电位与组织细胞在兴奋时产生的动作电位均有激活作用。  The mediated augmentation material capsaicin alkaloid activates the cell potential of the human body surface, and activates the membrane potential of the tissue cells in a resting state and the action potential generated by the tissue cells during excitement.
本发明将电气石和 /或晶体红外材料超细至纳米级或亚纳级粒径, 其超细粒子与介导强 化材料的分子混合, 通过本发明的物理技术, 使其相互包埋, 材料原有的特性, 超细纳米 化后粒子的新特性和包埋复合后的共轭作用, 使本发明材料可以产生对人体表面神经细胞 有特定的人体生物电网络节点激越作用。  The invention ultrafines the tourmaline and/or crystal infrared material to the nanometer or sub-nano grain size, and the ultrafine particles and the molecules of the mediated strengthening material are mixed, and are embedded in each other by the physical technique of the invention, the material original Some characteristics, the new characteristics of the particles after ultrafine nanocrystallization and the conjugation after embedding and recombination, enable the material of the present invention to produce a node-like agitation effect on the human body surface of the human body.
无论是现代西方医学还是东方医学都已经证明, 脑一身一心是三维一体的整体, 神经系 统是人体整体系统的优势系统。 生物电是人体生命的火花, 决定人体的生与死。 神经系统通 过纷繁复杂的网络向人体全身输布、反馈信息与能量。神经系统最小的结构单位是神经元(神 经细胞),人一生下来体内含有上千亿神经元, 并在以后不断产生这种细胞。每个神经元都有 一个细胞体, 里面包含了细胞的遗传物质; 另有树突, 细胞体的分支, 呈树枝状, 用以接收 信息; 还有轴突, 细胞体的一条细长分支, 用以传导细胞体的神经冲动。 单个神经元并没有 明确的任务分工, 只是作为载体通过电流形式传递信息。 一个神经元有数以千计的树突, 它 们与其他神经元发生联系, 从而构成人体的生物电网络。 神经元相互之间极为接近, 但并不 接触; 每个神经元之间的间隙称为突触。 我们每个人身上有 100万亿这种的突触。 人体有病 变时, 首先是在这个优势系统出现障碍, 具体体现在生物电网络某种障碍, 并在人体体表形 成敏感区或敏感点。  Both modern western medicine and oriental medicine have proved that the brain is a three-dimensional whole body, and the nervous system is the dominant system of the human body's overall system. Bioelectricity is the spark of human life, which determines the life and death of the human body. The nervous system transmits and feeds information and energy to the human body through a complex network. The smallest structural unit of the nervous system is the neuron (the nerve cell), which contains hundreds of billions of neurons in the body and continues to produce such cells in the future. Each neuron has a cell body that contains the genetic material of the cell; another dendrite, a branch of the cell body that is dendritic to receive information; and an axon, a slender branch of the cell body, The nerve impulse used to conduct the cell body. A single neuron does not have a clear division of tasks, just as a carrier to convey information through current. A neuron has thousands of dendrites that are associated with other neurons to form the body's bioelectrical network. The neurons are very close to each other but not in contact; the gap between each neuron is called a synapse. There are 100 trillion of these synapses on each of us. When the human body is sick, the first is the obstacle in this dominant system, which is embodied in some obstacles in the bioelectric network, and forms sensitive or sensitive points on the human body surface.
本发明功能材料, 通过其产生的特定生物电网络节点激越作用, 对人体表面 (皮肤或 粘膜) 节点或敏感点 (穴位) 神经元给予极其细微的调节, 影响神经系统的某些化学物质, 能够透过神经元这层突触, 使某种发生生物电网络一个神经元的轴突与另一个神经元的树 突发生联系, 解除这种受阻, 使因其受阻产生对脑的电位活动, 包括电压、 速度 、 节律、 同步性产生影响障碍因素消除, 实现一种 "皮脑激越效应", 使疾病得以有效治疗, 人体得 以康复。  The functional material of the present invention, through the agitation of a specific bioelectric network node generated by the invention, imparts extremely fine adjustment to a human body surface (skin or mucous membrane) node or a sensitive point (acupoint) neuron, affecting certain chemicals of the nervous system, capable of Through the synapse of neurons, a certain axon of a neuron in a bioelectrical network is linked to the dendrites of another neuron, and this resistance is removed, causing potential activity on the brain due to its obstruction. Including voltage, speed, rhythm, and synchrony, the influence factors are eliminated, and a "skin brain agitation effect" is realized, so that the disease can be effectively treated and the human body can be recovered.
本发明功能材料, 用作医疗器械或医疗器材材料, 制成各种医疗治疗器械与保健器材, 其发明技术至少有以下 6种明显优点。  The functional material of the present invention is used as a medical device or a medical device material to form various medical therapeutic devices and health care devices, and the invention has at least the following six distinct advantages.
1、治疗安全性好。本发明所采用的原材料,是现有技术已经证明了对人体无害的物质。 本发明的功能材料制成医疗器械或器材治疗各种慢性疾病, 是人体表面疗法, 不进入人体 体内, 不对人体产生毒副作用, 在可以替代药物治疗的慢性疾病治疗中, 可以有效克服慢 性疾病药物治疗毒副作用的这一世界性难题。  1, the treatment is safe. The raw material used in the present invention is a substance which has been proven to be harmless to the human body in the prior art. The functional material of the invention is made into a medical device or a device for treating various chronic diseases, and is a surface treatment of the human body, does not enter the human body, does not cause toxic and side effects to the human body, and can effectively overcome the chronic disease drug in the treatment of chronic diseases which can replace the drug treatment. This worldwide problem of treating toxic side effects.
2、 操作性能好。 本发明的功能材料制作的医疗器械与器材, 运用了材料的特殊性能, 可以不用电、 不用磁、 无放射性, 操作不用接电源或接其他能源, 同时不含 电器元件, 不 会损坏, 不需要维修, 并且治疗操作简单, 可以实现复杂的治疗原理简单重复操作, 很好 地解决了现有技术治疗器械需有源、 维修难与操作不易的难题。 2. Good operating performance. The medical device and the device made of the functional material of the invention utilize the special properties of the material, It can be used without electricity, no magnetism, no radioactivity, no power supply or other energy source, no electrical components, no damage, no maintenance, and simple operation. It can realize complex treatment principle and simple repeat operation. It solves the problem that the prior art therapeutic instruments need to be active, difficult to maintain and difficult to operate.
3、 十分经久耐用。 本发明的功能材料制作的医疗器械与器材, 可实现有效治疗 1-2万 次(每次治疗使用 1小时), 如果每个人(或家庭)每天治疗使用 2次, 使用寿命可达到 10 年以上。  3, very durable. The medical device and equipment made of the functional material of the invention can effectively treat 1-2 million times (1 hour for each treatment), and if each person (or family) uses the treatment twice a day, the service life can reach more than 10 years. .
4、 节省治疗费用。 本发明的功能材料, 材料生产成本很低, 同时, 其使用寿命很长, 因此, 每次治疗成本超于寻常的低廉。 如果按生产成本与使用次数计算, 每次治疗成本极 其低廉。 这十分有利于降低现有药物治疗慢性病的高昂费用, 抑制医疗费用的上涨。  4. Save on treatment costs. The functional materials of the present invention have low production costs and, at the same time, have a long service life, and therefore, the cost per treatment is more than ordinary. If the cost of production and the number of uses are calculated, the cost per treatment is extremely low. This is very beneficial to reduce the high cost of existing drugs for the treatment of chronic diseases and to curb the increase in medical expenses.
5、 适用疾病广谱。 本发明的功能材料制作治疗性医疗器械与器材, 由于其作用原理的 新颖、 独特, 可适用于非感染性、 非营养性的各种慢性疾病的康复治疗。  5. Applicable broad spectrum of diseases. The functional materials of the invention make therapeutic medical devices and equipments, and because of the novel and unique mechanism of action, the invention can be applied to the rehabilitation treatment of various chronic diseases of non-infective and non-nutritional.
6、 疗效稳定可靠。 本发明的功能材料制作治疗器械治疗慢性病, 疗效稳定可靠。 初步 验证疗效的一部分资料如下:  6, the effect is stable and reliable. The functional material of the invention makes a therapeutic device for treating chronic diseases, and the curative effect is stable and reliable. Some of the preliminary validation results are as follows:
( 1 )本发明所制成的硬固体功能片治疗学生脑疲劳效果研究。  (1) A hard solid functional tablet made by the present invention is used to treat brain fatigue effects of students.
1对象与方法 1 objects and methods
1. 1对象  1. 1 object
实验对象为 120名, 身体健康状况相同, 年龄在 21-22岁的在校大学三年级学生。 男 女生各 60名。男生体重为 55- 65Kg,身高 170- 180cm;女生体重为 50-55Kg,身高 160- 167cm. 实验对象的基础脉搏在 65-70次 /秒之间。  The subjects were 120 students with the same physical health status and the third-year university students aged 21-22. 60 male and female girls. Boys weigh 55-65Kg and height 170-180cm; girls weigh 50-55Kg and height 160-167cm. The basic pulse of the subject is between 65-70 beats/sec.
1. 2方法  1. 2 methods
经过问卷调査了解到这些同学持续性学习产生的脑疲劳及出现的各种影响学习的不良生理 状况见表一。 After a questionnaire survey, we learned that the brain fatigue caused by continuous learning of these students and the various adverse physiological conditions that affect learning are shown in Table 1.
表一 学生未进行自我调控时脑疲劳状态调査表  Table 1 Brain fatigue status questionnaire when students do not self-regulate
Figure imgf000006_0002
Figure imgf000006_0002
Figure imgf000006_0001
Figure imgf000006_0001
治疗方法: 采用本发明所制成的硬固体功能片, 选择敏感点定神穴, 穴位位置 : 前额 正中中点, 印堂穴上 0. 5寸处。 治疗时, 将功能片置于定神穴上, 用丝带围绕头部一周系 紧, 一次治疗 1小时, 每天 2次, 上下午各 1次, 可于上课或者学习中治疗。  Treatment method: The hard solid functional tablet made by the invention is used, and the sensitive point is selected, and the acupuncture position is: the midpoint of the forehead, and the 0.5 inch at the Yintang. During treatment, the functional piece is placed on the fixed acupoint, and the ribbon is tied around the head for one week. One treatment for one hour, two times a day, and one for each afternoon, can be treated in class or study.
2 结 果  2 results
通过功能片治疗, 一次即有效果, 坚持治疗 1个月, 脑疲劳状态的恢复效果见表二。  Through functional tablets treatment, once effective, adhere to treatment for 1 month, the recovery effect of brain fatigue state is shown in Table 2.
表二 学习进行自我调控后脑疲劳状态调査表
Figure imgf000007_0001
Table 2: Study on the state of brain fatigue after self-regulation
Figure imgf000007_0001
从表中可以看出, 使用功能片治疗前后比较学习疲劳时间, 二者差异有显著性。 t=6. 145, P<0. 05 (以 a=0. 05为检验显著性标准)。 使用功能片治疗前后 1小时英语记忆力比 较, 二者差异有显著性, t=10. 104, P〈0. 05, 大脑疲劳症状, 使用功能体治疗后发现出现某 一症状的人数 (如乏力), 及出现两种及多种并发症状的人数 (如头晕 +眼花)均有显著减 少。  It can be seen from the table that the difference in learning fatigue time before and after treatment with functional tablets is significant. t=6. 145, P<0.05 (with a=0. 05 as the test for significance). The functional memory was compared 1 hour before and after treatment with functional tablets. The difference was significant, t=10. 104, P<0.05, brain fatigue symptoms, the number of people who developed a symptom after treatment with functional body (such as fatigue) , and the number of people with two or more complications (such as dizziness + vertigo) was significantly reduced.
(2)本发明所制成的硬固体功能片治疗学习困难儿童临床对照研究  (2) A clinical study of a hard solid functional tablet prepared by the present invention for treating children with learning difficulties
1 临床资料  1 Clinical data
1. 1研究对象: 以智力正常, 但学习成绩不及格或老师评为差生, 或上年度因学习成绩 不好留级, 同时伴有行为异常的门诊儿童为研究对象。 随机分为治疗组与对照组。 治疗组 1. 1 Study subjects: Out-of-school children with normal intelligence, but failing to pass grades or teachers as poor students, or poor grades in the previous year due to poor academic performance, and outpatients with behavioral abnormalities. They were randomly divided into treatment group and control group. therapy group
92人, 其中男 68人, 女 24人, 年齢 6岁- 14岁, 平均 11岁; 对组 50人, 男 32人, 女 18 人, 年龄 6- 16岁, 平均 11岁。 92 people, including 68 males and 24 females, aged 6 years old - 14 years old, average 11 years old; 50 people in the group, 32 males and 18 females, aged 6-16 years, average 11 years old.
1. 2测试工具:采用中国韦氏儿童智力量表,对所有被试进行前后两次测试。间隔时间: 治疗组为 30- 52天, 平均 38天; 对照 组为 30- 60天, 平均 40天。 测试结果统一评分。  1. 2 test tools: using the Chinese Wechsler Children's Intelligence Scale, all subjects were tested twice before and after. Intervals: The treatment group was 30-52 days with an average of 38 days; the control group was 30-60 days with an average of 40 days. The test results were uniformly scored.
1. 3治疗方法: 将功能片置于敏感点定神穴位上(定神穴位置在前额正中中点, 印堂穴 上 0. 5寸), 用丝带围绕头部系紧, 每次治疗 1小时, 每天上、 下午各一次。 可在课间时间 治疗。  1. 3 treatment method: Place the functional piece on the sensitive point of the acupoint (the position of the gods is at the midpoint of the forehead, 0.5 inch on the Yintang hole), tighten the head around the head with a ribbon, each treatment for 1 hour, daily Once in the afternoon and in the afternoon. It can be treated during class time.
2 结 果  2 results
2. 1治疗组与对照组各分测量表分及智商值、记忆商值、学习成绩的比较。 (见表 1 )  2. 1 Comparison of the measured scores and IQ, memory quotient, and academic scores between the treatment group and the control group. (See Table 1)
表 1两组各分测验量表分及智商、 记忆商、 学习成绩的比较 测验 治 疗 组 对 照 组 t捡验(P值)  Table 1 Comparison of the scores of the two groups of test scores and IQ, memory, and academic scores Tests for the treatment group t test (P value)
治疗前 (1 ) 治疗后 (2 ) 初测 (3) 复测 (4) 1: 2 3: 4 1: 3 2: Before treatment (1) After treatment (2) Initial test (3) Retest (4) 1: 2 3: 4 1: 3 2:
44
R 7. 43 (2.65) 9.48 (2. 17) 7. 56 (2.87) 7. 32 (3.04) * * NS NS * * 分类 8. 63 (2. 65) 10. 50 (2. 14) 7.44 (2. 68) 7. 16 (2.70) * * NS NS * * m 7.87 (3. 12) 10. 28 (2.77) 7.32 (2.25) 7.76 (2.31) * * NS NS * * c 7.96 (2.66) 9. 17 (2.43) 7. 04 (2. 61) 7. 24 (2.09) * * NS NS * * 领悟 8. 13 (2.49) 9. 67 (2.24) 7.92 (3.01) 7. 24 (3.26) * * NS NS * * 徽 8.00 (2. 37) 9. 11 (1.69) 7.64 (2.48) 8. 32 (2.39) * * NS NS NS* * 填图 8.02 (3.45) 9.22 (2.42) 7.48 (3.03) 7. 68 (2.91) * * NS NS * 排图 8.73 (2. 38) 10.52 (2. 9) 8.36 (2.64) 8.68 (3.05) * * NS NS * * 称 9.20 (2.56) 10.13 (2.38) 8.72 (2.87) 8.28 (3.30) * * NS NS * * 纖 8.72 (3.05) 10.00 (2.65) 8.64 (2.89) 8.44 (3.84) * * JS * R 7. 43 (2.65) 9.48 (2. 17) 7. 56 (2.87) 7. 32 (3.04) * * NS NS * * Classification 8. 63 (2. 65) 10. 50 (2. 14) 7.44 ( 2. 68) 7. 16 (2.70) * * NS NS * * m 7.87 (3. 12) 10. 28 (2.77) 7.32 (2.25) 7.76 (2.31) * * NS NS * * c 7.96 (2.66) 9. 17 (2.43) 7. 04 (2. 61) 7. 24 (2.09) * * NS NS * * Comprehend 8.13 (2.49) 9. 67 (2.24) 7.92 (3.01) 7. 24 (3.26) * * NS NS * * Emblem 8.00 (2. 37) 9. 11 (1.69) 7.64 (2.48) 8. 32 (2.39) * * NS NS NS* * Fill in Figure 8.02 (3.45) 9.22 (2.42) 7.48 (3.03) 7. 68 (2.91) * * NS NS * Figure 8.73 (2. 38) 10.52 (2. 9) 8.36 (2.64) 8.68 (3.05) * * NS NS * * Weighing 9.20 (2.56) 10.13 (2.38) 8.72 (2.87) 8.28 (3.30) * * NS NS * * Fiber 8.72 (3.05) 10.00 (2.65) 8.64 (2.89) 8.44 (3.84) * * JS *
7.59 (2.68) 9.52 (2.18) 7.20 (3.54) 8.64 (3.13) * * NS NS NS 7.59 (2.68) 9.52 (2.18) 7.20 (3.54) 8.64 (3.13) * * NS NS NS
86.46 (10.40) 96.70 (9.51) 82.88 (14.00) 82.16(11.71) * * NS NS * *86.46 (10.40) 96.70 (9.51) 82.88 (14.00) 82.16 (11.71) * * NS NS * *
88.33(13.39) 99.11 (11.43) 85.46 (16.90) 87.48 (17.74) * * NS NS * * 全械 85.91 (9.83) 98.50 (4.77) 82.56 (14.99) 83.34 (13.28) * * NS NS * * 记! >乙商 71.71 (12.64) 98.50 (4.77) 79.40 (13.54) 90.00 (15.60) * * NS NS * * 觸 66.61 (12.6) 84.98 (6.36) 67.88 (13.14) 72.38 (9.45) * * NS NS * * 注: * *表示 P<0.01, *表示 P <0.O5, NS表示 P>0.05, 下同。 88.33(13.39) 99.11 (11.43) 85.46 (16.90) 87.48 (17.74) * * NS NS * * Full Machinery 85.91 (9.83) 98.50 (4.77) 82.56 (14.99) 83.34 (13.28) * * NS NS * * Remember! > B 71.71 (12.64) 98.50 (4.77) 79.40 (13.54) 90.00 (15.60) * * NS NS * * Touch 66.61 (12.6) 84.98 (6.36) 67.88 (13.14) 72.38 (9.45) * * NS NS * * Note: * * It means P<0.01, * means P<0.O5, and NS means P>0.05, the same below.
从表 1 中可见, 治疗组与对照组在初次测试时, 结果无显著差异, 说明两组受试者来 自同一总体, 具有可比性。 但治疗后第二次测试发现, 治疗组的分数明显高于对照组, 经 t 检验, 都有显著差异(P〈0.05), 这是由于治疗组经过硬固体功能片治疗后各分数较第一次 有了明显提高, 而对照 组由于练习效应的影响, 分数有所提高, 但不明显。  It can be seen from Table 1 that there was no significant difference between the treatment group and the control group at the initial test, indicating that the two groups of subjects came from the same population and were comparable. However, the second test after treatment found that the score of the treatment group was significantly higher than that of the control group, and there was a significant difference by the t test (P<0.05). This was because the treatment group had the first score after the hard solid functional tablet treatment. There was a significant increase in the number of times, while the control group increased the score due to the effect of the exercise, but it was not obvious.
2.2治疗组与对照组前后两次测试分数差值的比较(见表 2)  2.2 Comparison of the scores of the two test scores before and after treatment between the treatment group and the control group (see Table 2)
为了更好地判明治疗效果, 消除第二次测试时因第一次产生的练习效应的影响, 我们 对治疗组与对照组前后两次测试的分数差值进行了比较, 同样发现两组结果具有显著差异 (除背数、 填图、 编码 3个分没验 P值 >0.05外, 余均 <0.05或〈0.01) .此外我们还发现, 治疗开始时病情重对治疗疗效无明显影响 (P<0.05)。  In order to better understand the therapeutic effect and eliminate the influence of the first exercise effect in the second test, we compared the difference scores between the two groups before and after the treatment group and the control group. Significant differences (except for the number of backs, mapping, coding, 3 points, P value > 0.05), and the average of <0.05 or <0.01). In addition, we also found that the severity of the treatment at the beginning of treatment had no significant effect on the therapeutic effect (P< 0.05).
表 2两组前后两次测试分数差值的比较  Table 2 Comparison of the scores of the two test scores before and after the two groups
« 治 疗 组 对 照 组 P¾  « Treatment group control group P3⁄4
X SD X SD  X SD X SD
知识 2.04 2.75 -0.24 2.60 * * Knowledge 2.04 2.75 -0.24 2.60 * *
分类 1.87 1.98 - 0.28 2.17 * * Classification 1.87 1.98 - 0.28 2.17 * *
算术 2.41 2.53 0.4 2.47 * * Arithmetic 2.41 2.53 0.4 2.47 * *
领悟 L 54 2.47 -0.68 2.78 * * Comprehension L 54 2.47 -0.68 2.78 * *
词汇 1.22 2.16 0.20 2.36 * Vocabulary 1.22 2.16 0.20 2.36 *
冃数 1.11 2.35 0.68 2.48 NS  Number of parameters 1.11 2.35 0.68 2.48 NS
填图 1.20 2.79 0.20 3.73 NS Fill in the picture 1.20 2.79 0.20 3.73 NS
排图 1.89 2.68 0.32 2.43 * Row 1.89 2.68 0.32 2.43 *
积木 0.93 1.90 -0.44 2.95 * Building blocks 0.93 1.90 -0.44 2.95 *
拼物 1.28 2.05 -0.20 2.84 Composition 1.28 2.05 -0.20 2.84
编码 1.93 2.15 1.44 3.04 NS Code 1.93 2.15 1.44 3.04 NS
言语智商 11.24 5.97 -0.72 7.52 水 * Verbal IQ 11.24 5.97 -0.72 7.52 Water *
操作智商 10.78 8.03 1.92 11.58 * * Operational IQ 10.78 8.03 1.92 11.58 * *
全智商 12.2S 4.43 0.68 7.22 水 * All IQ 12.2S 4.43 0.68 7.22 Water *
记忆商 26.79 11.70 10.60 12.24 * Memory quotient 26.79 11.70 10.60 12.24 *
成绩 18.37 9.59 4.50 16.41 * * (3)本发明所制成的功能体控制海洛因依赖戒断症状 65例即时疗效观察 Grade 18.37 9.59 4.50 16.41 * * (3) The immediate efficacy of 65 cases of heroin-dependent withdrawal symptoms controlled by the functional body made by the invention
1 临床资料 1 Clinical data
1. 1病例选择  1. 1 case selection
住院禁用海洛因 72小时吸毒者,用阿片激动剂替代脱毒,当递减剂量后发作戒断症状。 诊断标准按 DSM- ΙΠ- R, 符合阿片撤药综合征标准, 排除由于其他任何躯体或精神、 心理障 碍者。  Heroin was banned in hospital for 72-hour drug users, opioid agonists were used to replace detoxification, and withdrawal symptoms were observed when the dose was decreased. Diagnostic criteria are based on DSM-ΙΠ-R, which meets the criteria for opioid withdrawal syndrome and excludes any other physical or mental or mental disorders.
1. 2—般情况  1. 2-General situation
功能体治疗组 65例, 其中男 40例, 女 25例; 年龄最小 18岁, 最大 38岁, 平均年龄 26. 3岁; 吸毒病程: 1年内 26例, 1-2年 31例, 2年以上 8例; 吸毒方式: 香烟吸 3例, 烫吸 42例, 注射 20例; 末周每日吸毒量平均 1. 36g.  There were 65 patients in the functional group, including 40 males and 25 females; the youngest was 18 years old, the largest was 38 years old, and the average age was 26.3 years old; the course of drug abuse: 26 cases in 1 year, 31 cases in 1-2 years, more than 2 years 8 cases; drug use: 3 cases of cigarette smoking, 42 cases of scalding, 20 cases of injection; the average daily dose of 1. 36g.
另选择同期住 所用药物控制戒断症状者 38例作为对照组。 其中用盐酸二氢埃托啡(DHZ) 20例, 盐酸丁丙诺啡 (BUP) 18例; 性别: 男 28例, 女 10例; 年龄最小 18岁, 最大 48 岁, 平均年龄 26. 9岁; 吸毒病程: 1年内 12例, 1-2年 20例, 2年以上 6例; 吸毒方式: 香烟吸 2例, 烫吸 25便, 注射 11例, 末周每日平均吸毒量 1. 30g. Another 38 patients who underwent drug control for withdrawal symptoms at the same time were selected as the control group. Among them, 20 cases of dihydroetorphine hydrochloride (DHZ) and 18 cases of buprenorphine hydrochloride (BUP); gender: 28 males and 10 females; youngest 18 years old, maximum 48 years old, average age 26.9 years old The course of drug abuse: 12 cases in 1 year, 20 cases in 1-2 years, 6 cases in 2 years or more; Drug abuse: 2 cases of cigarette smoking, 25 cases of scalding, 11 cases of injection, the average daily dose of drug in the last week was 1. 30g.
治疗组与对照组基础用药大致相同。  The treatment group and the control group were basically the same.
2治疗方法 2 treatment methods
2. 1仪器  2. 1 instrument
本发明制作的功能体, 可替代传统针灸、 按摩和现代电疗、 磁疗、 红外线治疗和化学 药物治疗。  The functional body produced by the invention can replace traditional acupuncture, massage and modern electrotherapy, magnetic therapy, infrared therapy and chemical therapy.
2. 2操作  2. 2 operations
敏感点选穴处方: 第 1组: 乳中 (双侧)、 印堂、 太阳 (双侧)、 中脘、足三里(双侧)、 神 门 (双侧)  Sensitive point selection prescription: Group 1: Milk (two sides), Yintang, Sun (two sides), Zhongmu, Zusanli (bilateral), Shenmen (two sides)
第 2组: 内关(双侧)、 外关(双侧)、 合谷(双侧)、 劳宫 (双侧)、 三阴交(双侧)  Group 2: Neiguan (bilateral), Waiguan (bilateral), Hegu (bilateral), Laogong (bilateral), Sanyinjiao (bilateral)
注: 如使用乳中穴不方便, 可改用安眠(双侧)  Note: If it is not convenient to use the milk acupoint, you can use sleep (two sides)
治疗时间: 第一周: 两组穴位上午、 下午交替使用, 每日两次。  Treatment time: Week 1: The two groups of points are used alternately in the morning and afternoon, twice daily.
第二周: 两组穴位交替使用, 每日一次。  Week 2: The two groups of acupuncture points are used alternately once a day.
第三周: 两组穴位任选一组, 隔日一次。  Week 3: Choose one of the two groups of points, once every other day.
使用时将功能体直接贴在所选敏感点穴位皮肤上, 用透气胶带固定, 每次治疗 1 小时 或根据症状适当延长时间治疗。  When using, directly attach the functional body to the skin of the selected sensitive point, fix it with breathable tape, treat it for 1 hour each time or extend the time according to the symptoms.
3疗效判定标准  3 efficacy criteria
采用制定的海洛因戒断症状量表, 治疗前后由经治医生登记评分, 戒断症状量表有 23 项观察指标, 每项指标评分标准是: 0分无症状; 1分症状轻微或偶有, 不要求治疗; 2分 症状明显,要求治疗但能忍受; 3分症状明显,要求治疗, 难以忍受。施治后观察起效时间, 每 5分钟记录 1次, 并记录维持时效。  Using the established heroin withdrawal symptom scale, before and after treatment, the doctors registered the score, the withdrawal symptom scale has 23 observation indicators, the score of each indicator is: 0 points asymptomatic; 1 point symptoms are mild or occasional, No treatment is required; 2 points are obvious, requiring treatment but can be tolerated; 3 points are obvious, requiring treatment, unbearable. After the treatment, the onset time was observed and recorded every 5 minutes, and the aging was recorded.
近期控制: 寻药行为、 渴求消失, 症状基本消失或轻微; 戒断症状量表积分 8分以下。 好转: 寻物行为, 渴求明显减弱, 症状明显减轻; 戒断症状积分在 8-15分之间。 无效: 症 状体征同治疗前, 戒断症状积分 15分以上; 偷吸或改用其它方法控瘾者。 Recent control: drug-seeking behavior, craving for disappearance, symptoms are basically disappeared or mild; withdrawal syndrome scores are less than 8 points. Better: Searching for behavior, hunger is significantly weakened, symptoms are significantly reduced; withdrawal symptoms are between 8-15 points. Invalid: Symptom Before the symptoms are treated, the withdrawal symptoms score is 15 points or more; stealing or switching to other methods to control the addict.
4 治疗结果 4 treatment results
4.1疗效观察  4.1 therapeutic observation
治疗组 65例中近期控制者 36例, 占 55.38%.有效 63例, 占 96.81%.与对照组比较, 即时疗效相近(X2- 0.041, P>0.05)。 见表 1. Among the 65 patients in the treatment group, 36 patients had recent control, accounting for 55.38%. 63 patients were effective, accounting for 96.81%. Compared with the control group, the immediate efficacy was similar (X 2 - 0.041, P > 0.05). See Table 1.
4.2戒断症状量表积分  4.2 withdrawal symptoms scale integral
海洛因戒断综合征临床表现不一, 但至少具备表 2中 4-5项才能诊断。 治疗后积分下 降情况见表 2.  Heroin withdrawal syndrome has different clinical manifestations, but at least 4-5 of Table 2 can be diagnosed. The post-treatment scores are shown in Table 2.
表 1 两组即时疗效比较  Table 1 Comparison of immediate effects between the two groups
分 组 例数 近控 好转 无效 有效率  Group number of cases, near control, improvement, invalid, efficient
治疗组 65 36 (55.38) 27 (41.53) 2 (3.09) 96.91  Treatment group 65 36 (55.38) 27 (41.53) 2 (3.09) 96.91
对照组 38 20 (52.63) 16 (42.11) 2 (5.26) 94.74 表 2治疗前后戒断症状量表积分(X土 S)  Control group 38 20 (52.63) 16 (42.11) 2 (5.26) 94.74 Table 2 Points of withdrawal symptoms before and after treatment (X soil S)
戒断症状 例数 治疗前 治疗后  Abstinence symptoms number of cases before treatment
打呵欠 35 1.95±0.67 0.65±0.65  Yawning 35 1.95±0.67 0.65±0.65
流泪流涕 65 2.09±0.74 1.43±0.67  Tears flowing 65 2.09±0.74 1.43±0.67
疲乏 60 1.87±0.47 1.65±0.82  Fatigue 60 1.87±0.47 1.65±0.82
烦躁不安 60 1.89 ±0.47 0.55±0.45  Irritable 60 1.89 ±0.47 0.55±0.45
失眠 40 1.80±0.64 1.10±0.56  Insomnia 40 1.80±0.64 1.10±0.56
忽冷忽热 43 2.03±0.63 0.57 土 0.41  Hot and cold 43 2.03±0.63 0.57 soil 0.41
头痛 20 2.00±0.28 0.75 ±0.54  Headache 20 2.00±0.28 0.75 ±0.54
周身疼痛 15 2.22±0.44 1.22±0.58  Pain in the body 15 2.22±0.44 1.22±0.58
胸闷 18 2.70±0.47 0.83±0.66  Chest tightness 18 2.70±0.47 0.83±0.66
恶心呕吐 9 2.66±0.52 1.57±0.55  Nausea and vomiting 9 2.66±0.52 1.57±0.55
腹痛腹泻 9 2.66±0.52 1.65±9.56  Abdominal pain and diarrhea 9 2.66±0.52 1.65±9.56
肌肉抽动 6 2.00 0  Muscle twitching 6 2.00 0
竖毛 60 1.90±0.47 0  Vertical hair 60 1.90±0.47 0
出冷汗 38 2.25±0.66 0.55 ±0.48  Cold sweat 38 2.25±0.66 0.55 ±0.48
皮肤虫咬感 6 2.00 0  Skin insect bite 6 2.00 0
渴求 65 2.10±0.76 0  Craving 65 2.10±0.76 0
心率加快 35 1.65±5.24 78.40±3.39  Heart rate is faster 35 1.65±5.24 78.40±3.39
※心率次数 /分  ※Heart rate / points
4.3两组起效时间的比较  4.3 Comparison of the onset time between the two groups
治疗组起效吋间在 15-25分钟,平均 5.90±4.85分;药物 DHE组起效迅速,平均 10.75 In the treatment group, the onset time was 15-25 minutes, with an average of 5.90±4.85 points; the drug DHE group was effective, with an average of 10.75.
±2.93分; 药物 BUP起效较缓, 平均 27.22±3.52分。 见表 3. ± 2.93 points; drug BUP has a slower onset, with an average of 27.22 ± 3.52 points. See table 3.
表 3 两组起效时间的比较 单位: 例 (%) 对照组 Table 3 Comparison units of the two groups of onset time: Example (%) Control group
时间 (分) 治疗组 DHE BUP  Time (minutes) treatment group DHE BUP
"5=Ίϋ 18(27.69) 15(75.00) =  "5=Ίϋ 18(27.69) 15(75.00) =
11-15 25(38.46) 5(25.00) ——  11-15 25(38.46) 5(25.00) ——
16-20 15(23.07) —— 2(11.11)  16-20 15(23.07) —— 2(11.11)
21-25 7 (10.76) —— 6 (33.33)  21-25 7 (10.76) —— 6 (33.33)
26-30 —— —— 10 (55.56)  26-30 —— —— 10 (55.56)
4.4治疗组疗效与吸毒病程的关系  4.4 The relationship between the efficacy of the treatment group and the course of drug abuse
吸毒病程在 2年内者疗效较好, 2年以上者疗效略差。 见表 4.  The course of drug abuse is better in 2 years, and the effect is slightly worse in 2 years or more. See table 4.
表 4 疗效与滥用时间的关系 单位: 例 (%)  Table 4 Relationship between efficacy and abuse time Unit: Example (%)
时 间 例数 近控 m ¾¾  Time number of cases near control m 3⁄43⁄4
<1年 26 16 (61.5) ^ 10 (38.5) 0  <1 year 26 16 (61.5) ^ 10 (38.5) 0
1-2年 31 19 (61.3) 12 (38.7) 0  1-2 years 31 19 (61.3) 12 (38.7) 0
>2年 8 2 (25.0) 4 (50.0) 2 (25.0)  >2 years 8 2 (25.0) 4 (50.0) 2 (25.0)
―" ·¾ -^? KX2=0.026 ~~ Ρ>0.05,※〜※※※^.34 Ρ=0.05 ―" ·3⁄4 -^? KX 2 =0.026 ~~ Ρ>0.05,※~※※※^.34 Ρ=0.05
其原因是迁延性戒断症状可以不同程度持续 一段时间和精神性依赖性症状较长时间 存在, 加之在康复阶段缺少有效而又不成瘾的药物, 导致脱毒后复吸。  The reason for this is that persistent withdrawal symptoms can persist for varying degrees of time and mentally dependent symptoms for a longer period of time, and the lack of effective and non-addictive drugs during the rehabilitation phase leads to relapse after detoxification.
本资料采用功能体治疗观察 65例, 近期控制率 55.38%, 有效率 96.91%, 提示为戒毒 康复阶段治疗的一种有效方法。  This data was observed by functional body treatment in 65 cases, with a recent control rate of 55.38% and an effective rate of 96.91%, suggesting an effective method for the treatment of rehabilitation.
5.1临床疗效的评估  5.1 Evaluation of clinical efficacy
治疗组与对照组均能控制戒断症状的发作, 即时疗效相近。 药物 DHZ属阿片受体激动 剂,有较强替代海洛因的作用, BUP属阿片受体半激动、半拮抗剂, 能部分替代海洛因作用。 但前者有明显的躯体、 精神性依赖, 不宜久用; 后者不良反应稍小, 但亦有成瘾之弊, 这 就限制了药物控瘾的使用时间。 采用本发明功能体治疗, 属纳米材料表面效应疗法, 无不 良反应、 安全度大、 重复治疗不会成瘾。  Both the treatment group and the control group can control the onset of withdrawal symptoms, and the immediate effects are similar. Drug DHZ is an opioid receptor agonist, which has a strong substitute for heroin. BUP is an opioid receptor semi-agonist and semi-antagonist, which can partially replace heroin. However, the former has obvious physical and mental dependence and should not be used for a long time. The latter has a small adverse reaction, but it also has the disadvantage of addiction, which limits the use time of drug addiction. The treatment with the functional body of the invention belongs to the surface effect therapy of nano materials, has no adverse reaction, is safe, and is not addictive to repeated treatment.
从表 2戒断症状量表积分评分: 治疗前戒断症状平均积分 34.12, 治疗后 13.07, 均 分差 21.05.治疗前后比较有显著差异(t=4.91 P<0.01) .量表提示治疗组对抑制交感神经 兴奋性有明显作用, 表现为竖毛、 出冷汗、 皮肤虫咬感、 渴求症状消失, 心率增快 35例平 均减少 13.25次。  From Table 2, the withdrawal symptom score score: the average score of withdrawal symptoms before treatment was 34.12, 13.07 after treatment, and the difference was 21.05. There was significant difference before and after treatment (t=4.91 P<0.01). The scale suggested that the treatment group Inhibition of sympathetic nerve excitability has a significant effect, manifested as vertical hair, cold sweat, skin insect bite, craving for symptoms disappeared, heart rate increased in 35 cases, the average reduction of 13.25 times.
5.2起效时间的评估  5.2 Evaluation of onset time
表 3显示治疗组中起效时间在 15分者居多, 占 38.63%, 最快 3例 5分钟起效, 最慢 25分钟, 这与个体差异有关。 即生物电网络经络敏感性不同, 故起效快慢不一。 DHZ起效 迅速, 以 10分钟者居多, 占 75.0°/。; BUP起效较慢, 以 30分钟者居多, 占 55.56%.由此看 来: 本发明功能体起效时间不及 DHZ快, 但快于 BUP  Table 3 shows that the onset time of the treatment group was 15 points, accounting for 38.63%, the fastest 3 cases were effective for 5 minutes, and the slowest was 25 minutes, which was related to individual differences. That is to say, the meridian sensitivity of the bioelectric network is different, so the effect is different. DHZ works quickly, mostly in 10 minutes, accounting for 75.0°/. BUP has a slower effect, which is mostly in 30 minutes, accounting for 55.56%. From this point of view: The functional body of the invention has less effective time than DHZ, but faster than BUP.
5.3疗效与滥用时间分析  5.3 Analysis of efficacy and abuse time
吸毒史在 2年内者疗效明显, 2年以上者即时疗效较差, 与药物控瘾亦相一致。 吸毒时 间长则用药剂量增大。 国内学者研究发现: 吸毒者半年内超氧化物歧化酶活力正常或轻度 上升, 吸毒史愈长, 其活力水平愈下降, 细胞 cAMP水平降低。 本资料 65例中 2例无效者 吸毒史为 6年及 28年, 这可能与酶活性的降低、 机体抗氧化防御系统受损、 抗氧化能力降 低有关。 The history of drug abuse is obvious in 2 years, and the immediate effect is worse in those with more than 2 years, which is consistent with drug addiction. When the drug use time is long, the dosage is increased. Domestic scholars have found that: drug users have normal or mild superoxide dismutase activity within half a year. Rising, the longer the history of drug abuse, the lower the level of vitality and the decrease in cellular cAMP levels. The history of drug abuse in two of the 65 patients was 6 years and 28 years, which may be related to the decrease of enzyme activity, damage to the body's antioxidant defense system, and decreased antioxidant capacity.
(4)本发明所制成的功能体治疗眩暈 54例临床总结  (4) The functional body made by the invention treats vertigo in 54 cases
1、 临床资料  1. Clinical data
54例中, 门诊 24例, 住院 30例; 男 21例, 女 33例; 年龄最小 17岁, 最大 87 岁,平均 50岁; 病程最短 0. 5天, 最长 21年, 平均 2. 2年。其中脑动脉硬化症 25例, 高血压病 10例, 颈椎病 8例, 美尼尔氏综合征 14例, 更年期综合征 2例, 高粘血症 3 例, 神经衰弱征候群 2例, 脑外伤后遗症 1例, 慢性酒精中毒 2例, 全部病例均以眩 晕为主症。  Of the 54 cases, 24 were outpatients and 30 were hospitalized; 21 males and 33 females; the youngest was 17 years old, the largest was 87 years old, with an average of 50 years; the shortest course was 0.5 days, the longest 21 years, the average was 2. 2 years. . There were 25 cases of cerebral arteriosclerosis, 10 cases of hypertension, 8 cases of cervical spondylosis, 14 cases of Meniere's syndrome, 2 cases of climacteric syndrome, 3 cases of hyperviscosity, 2 cases of neurasthenia syndrome, brain trauma. There were 1 case of sequelae and 2 cases of chronic alcoholism. All cases were mainly vertigo.
2、 治疗方法  2, treatment
全部病例均以功能体治疗, 选取敏感点穴位:  All cases were treated with functional body, and sensitive points were selected:
主穴: 百会, 太阳, 内关, 足三里。  Main points: Baihui, Sun, Neiguan, Zusanli.
配穴: 肾阴不足酌加太溪、 肾俞; 气血亏虚酌加膈俞、 脾俞; 痰浊中阻丰隆、 脾俞; 风阳上扰酌加太冲、 风池。  Acupoints: Kidney yin deficiency, plus Taixi, Shenshu; qi and blood deficiency, plus sputum, spleen; turbidity in the middle of the block, Fengshu, spleen; Fengyang on the discretion plus Tai Chong, wind pool.
操作: 用眩晕症专用功能体贴主穴及依据辨证分型酌加配穴。 治疗时, 选准穴位后, 将功能体治疗面贴住穴位, 用透气胶布固定, 每次治疗 1小时后取下。  Operation: Use the special function of vertigo to care for the main point and add points according to the syndrome differentiation. At the time of treatment, after selecting the acupoints, stick the functional body treatment surface to the acupuncture points, fix it with a breathable tape, and take it off after 1 hour of treatment.
3、 治疗结果  3, treatment results
54例中, 临床治愈(症状完全消失, 能正常参加工作和生活) 43例; 好转(症状 明显减轻) 38例; 无效(治疗前后症状无明显变化) 2例.总有效率 96. 2%。平均治愈 时间 18天。  Of the 54 cases, clinical cure (symptoms completely disappeared, able to participate in work and life normally) 43 cases; improved (symptoms were significantly reduced) 38 cases; ineffective (no significant changes before and after treatment) 2 cases. Total effective rate 96. 2%. The average healing time is 18 days.
(5)本发明所制成的功能体治疗中风后遗症 50例临床观察  (5) Clinical observation of 50 cases of stroke sequelae treated by functional body made by the invention
1、 一般资料  1. General information
50例患者中男 38例, 女 12例。 发病年龄最小的 33岁, 最大的 76岁; 病程最短 的 2周, 最长的 1年以上; 病程在 3个月以内的 46例, 3个月以上者 4例。 按病灶分 脑溢血 30例, 脑栓塞 20例。  Of the 50 patients, 38 were male and 12 were female. The age of onset was 33 years old, the largest was 76 years old; the shortest course was 2 weeks, the longest was more than 1 year; 46 cases were within 3 months, and 4 cases were more than 3 months. According to the lesion, there were 30 cases of cerebral hemorrhage and 20 cases of cerebral embolism.
2、 治疗方法  2, treatment
2. 1敏感点取穴: 水沟、 内关、 劳宫、 曲池、 委中。 半身不遂者加肩髑、 合谷、 外关、 环跳、 阳陵泉、 足三里、 解溪、 昆仑、 太冲; 口眼歪斜者加地仓或颊车、 合谷、 内庭、 承泣、 阳白、 攒竹、 昆仑、 养老; 语言不利者加上廉泉、 通里、 亚门、 风 府、 天突、 三阴交。  2. 1 Acupoints for sensitive points: Shuigou, Neiguan, Laogong, Quchi, and Venezuela. Half-length person with shoulders, Hegu, Waiguan, Huanqiu, Yanglingquan, Zusanli, Xiexi, Kunlun, Taichong; mouth and eye slanting plus warehouse or cheek car, Hegu, inner court, Chengqi, Yangbai, 攒Bamboo, Kunlun, old-age care; language disadvantaged plus Lianquan, Tongli, Yamen, Fengfu, Tiantu, Sanyinjiao.
2. 2方法: 选取敏感点穴位后, 将功能体贴紧所选敏感点穴位, 用透气胶布固定或专用 松紧带固定, 每次贴 1小时, 每次用 4- 5个穴位, 各组穴位交替使用。 1日 1次, 10次为 1疗程; 1疗程结束后休息两天再行下 1疗程。  2. 2 Method: After selecting the sensitive acupuncture points, the functional body is attached to the selected sensitive points, and fixed with a breathable tape or a special elastic band. Each time for 1 hour, each time with 4-5 points, the acupuncture points of each group are used alternately. . 1 time, 1 time, 10 times for 1 course of treatment; 1 day after the end of the course of treatment, rest for 2 days and then 1 course of treatment.
3、 疗效标准  3, the standard of efficacy
言语清晰, 能单独行走, 上肢可高举及握物, 生活可以自理, 自我感觉与常人无 异者为痊愈; 言语较清晰, 可单独行走, 上肢可握物但感无力, 生活基本可以自理, 肢体偶有不适感者为显效; 言语不利但能表达基本意思, 上下肢肌力增强但功能恢复 不佳, 生活仍需他人照顾者为有效; 治疗前后无明显改变者为无效。 Clear speech, can walk alone, upper limbs can hold high and hold objects, life can take care of themselves, self-feeling and ordinary people are better than others; words are clearer, can walk alone, upper limbs can hold things but feel weak, life can basically take care of themselves, The occasional discomfort of the limb is markedly effective; the speech is unfavorable but can express the basic meaning, the upper and lower extremity muscle strength is enhanced but the function recovery is not good, and the life still needs the care of others; the person who has no obvious change before and after treatment is invalid.
、 临床疗效 , Clinical efficacy
痊愈者 17例占 34%; 显效者 16例占 32% ; 有效者 12例占 24% ; 无效者 5例占 10%。 总有效率为 90%。 其中最少治疗 1个疗程, 最多治疗 9个疗程。 平均治疗 3. 8 个疗程。  The recovery of 17 cases accounted for 34%; the effective cases of 16 cases accounted for 32%; the effective cases of 12 cases accounted for 24%; the invalid cases of 5 cases accounted for 10%. The total effective rate is 90%. Among them, at least 1 course of treatment and up to 9 courses of treatment. Average treatment 3. 8 courses of treatment.
病程与疗效的关系见表 1  The relationship between disease course and curative effect is shown in Table 1.
病位与疗效的关系见表 2  The relationship between disease position and curative effect is shown in Table 2.
表 1 疗效与病位关系表  Table 1 Table of relationship between efficacy and disease
例数 痊愈 显效 有效 无效 病例 例 ( ) 例 (%) 例 (%) 例 (%) 脑溢血 30 10 ( 35) 12 (40) 6 (18. 33) 2 (6. 67) 脑栓塞 20 6 ( 31. 5) 4 (20) 7 (33. 5) 3 ( 15)  Cases of recovery effective and effective cases ( ) Case (%) Case (%) Case (%) Cerebral hemorrhage 30 10 ( 35) 12 (40) 6 (18. 33) 2 (6. 67) Cerebral embolism 20 6 ( 31 5) 4 (20) 7 (33. 5) 3 ( 15)
表 2 疗效与病程关系表  Table 2 Relationship between efficacy and disease duration
例数 痊愈 显效 有效 无效  The number of cases is effective, effective, invalid
病例 例 例 例 例  Case example
卜 3月 46 15 15 12 4  Bu March 46 15 15 12 4
3月以上 4 1 2 1  March or more 4 1 2 1
(6)本发明所制成的功能体治疗便秘型肠易激综合征疗效观察 (6) Therapeutic effect of functional body made by the present invention on constipation-type irritable bowel syndrome
、 资料与方法 , Materials and Methods
1. 1临床资料  1. 1 clinical data
消化门诊收治便秘型肠易激综合征 50例, 均经实验室检査, 下消化道钡剂造影及 结肠镜检排除引起便秘的全身性疾病与肠道器质性疾病,均符合 1998年罗马会议标准。 其中男性 18例, 女性 32例, 年龄最大 63岁, 最小 15岁, 平均年龄 37岁; 病程最长 20年, 最短半年, 平均病程 5年。  In the digestive clinic, 50 cases of constipation-type irritable bowel syndrome were treated by laboratory examination. The lower digestive tract sputum angiography and colonoscopy excluded the systemic diseases and intestinal diseases caused by constipation. Meeting standard. There were 18 males and 32 females, the oldest 63 years old, the youngest 15 years old, and the average age was 37 years old. The longest course was 20 years, the shortest half year, and the average disease duration was 5 years.
1. 2辨证论治  1. 2 syndrome differentiation
主要分为两型, 即肝郁气滞型和心脾两虚型。 肝郁气滞型: 大便干或不甚干, 排 便艰涩难解, 每周少于 3次, 甚则 1周 1解, 腹胀痛连两胁, 口苦、 目眩, 症状随情 绪波动反复, 舌质淡, 苔薄白、 脉细弱无力。  Mainly divided into two types, namely liver qi stagnation type and heart and spleen deficiency type. Liver qi stagnation type: dry or not dry stool, difficult to resolve bowel movements, less than 3 times a week, even 1 week 1 solution, abdominal pain and even two threats, mouth pain, dizziness, symptoms with mood fluctuations, tongue Light, thin white fur, weak and weak.
50例患者肝郁气滞型 21例, 占 42% ; 心脾两虚型 29例, 占 58%。  Fifty patients had liver qi stagnation type in 21 cases, accounting for 42%; heart and spleen deficiency type in 29 cases, accounting for 58%.
1. 3治疗方法  1. 3 treatment methods
所有患者均经心理疏导, 消除患者焦虑、 抑郁等精神症状; 调整个人饮食, 增加 膳食 中植物纤维含量; 养成定时大便习惯, 改变排便时吸烟、 看书等不良习惯; 全部 停用中西药物。 然后在此基础上辨证敏感点取穴进行本发明功能体治疗。 基础方为双 侧大肠俞、 足三里及中腙。 肝郁气滞型加双侧阳陵泉、 行间, 心脾两虚型加双侧三阴 交及关元。 治疗时选用功能体, 将功能体贴在所选敏感点穴位上治疗 1 小时, 用松紧 带或透气胶布固定。 每 10天为 1疗程, 每天 1次; 每治疗两个疗程, 中间休息 2天, 观察期限为两个月。 All patients were psychologically counseled to eliminate mental symptoms such as anxiety and depression; adjust personal diet, increase plant fiber content in diet; develop regular bowel habits, change bad habits such as smoking and reading during defecation; Then, based on this, the sensitive points are dialected to perform the functional body treatment of the present invention. The basic side is bilateral large intestine Yu, Zusanli and Zhongyu. Liver qi stagnation type plus bilateral Yanglingquan, inter-line, heart and spleen deficiency type plus bilateral Sanyinjiao and Guanyuan. Select the functional body during treatment, apply the functional body to the selected sensitive point for 1 hour, use elastic With or with a breathable tape. 1 course every 10 days, once a day; 2 courses per treatment, 2 days in the middle, the observation period is two months.
、 疗效评定标准与结果 , efficacy evaluation criteria and results
2. 1疗效评定标准  2. 1 efficacy evaluation criteria
显效: 临床症状消失, 排便正常, 两月无复发。 有效: 临床症状明显改善, 排便 基本正常, 两月内复发。 无效: 临床症状及排便情况无明显改善, 或改求药物治疗。 2. 2结果  Significant effect: Clinical symptoms disappeared, bowel movements were normal, and there was no recurrence in two months. Effective: Significant improvement in clinical symptoms, normal bowel movements, recurrence within two months. Invalid: There is no significant improvement in clinical symptoms and defecation, or medication is required. 2. 2 results
50例患者肝郁气滞型显效 15例, 有效 4例, 无效 2例; 心脾两虚型显效 16例, 有效 9例, 无效 4例。总共显效 31例(占 61 % ),有效 13例(占 26% ),无效 6例(占 12% ), 总有效率为 88%。  Fifty patients had markedly effective liver qi stagnation in 15 cases, effective in 4 cases, and ineffective in 2 cases; heart and spleen deficiency type was markedly effective in 16 cases, effective in 9 cases, and ineffective in 4 cases. A total of 31 cases (61%) were effective, 13 cases (26%) were effective, 6 cases (12%) were ineffective, and the total effective rate was 88%.
(7)本发明所制成的功能体治疗高血压病 66例  (7) The functional body made by the invention treats 66 cases of hypertension
、 临床资料 , clinical information
本组共 66例, 其中男 41例, 女 35例。 年龄 45岁以下者 1例, 45例至 55岁者 22例, 55岁以上者 42例。 病程最短半年, 最长 9年, 血压诊断标准按 1978年全国心 血管疾病会议规定的 WHO诊断标准执行。 I期 12例, Π 47例, III期 7例。  There were 66 cases in this group, including 41 males and 35 females. There were 1 case of those under the age of 45, 22 cases of 45 cases to 55 years old, and 42 cases of those over 55 years old. The shortest course of the disease is half a year, and the longest is 9 years. The blood pressure diagnosis standard is implemented according to the WHO diagnostic criteria stipulated in the 1978 National Conference on Cardiovascular Diseases. There were 12 cases in stage I, 47 cases in stage I, and 7 cases in stage III.
治疗方法: 1敏感点穴位: 大椎、 内关、 降压穴、 太冲, 合谷、 风池(均取双侧)、 肝俞、 百会。  Treatment methods: 1 sensitive points: Dazhui, Neiguan, Jiangyan, Taichong, Hegu, Fengchi (both sides), Ganshu, Baihui.
、 方法: , method:
用本发明所制成的功能体治疗时, 将功能体贴在所选敏感点穴位上, 用松紧带或 透气胶带固定, 每次 1治疗 1小时, 每次用穴 4-5个, 各组穴位交替使用, 每天治疗 一次, 每 10次为一个疗程。 在此期间须戒烟酒, 慎恼怒, 保持大小便通畅, 停用任何 治疗方法。  When treating with the functional body made by the invention, the functional body is attached to the acupuncture points of the selected sensitive points, and is fixed by elastic band or gas permeable tape, and each treatment is for 1 hour, 4-5 times for each use point, and the acupuncture points of each group are alternated. Use, once a day, every 10 times for a course of treatment. During this period, you must quit smoking and alcohol, be cautious, keep your urine and urine open, and stop using any treatment.
疗效标准及结果: 66例观察半年, 痊愈(47例): 头痛、 头暈症状消失, 血压降 至正常, 随访半年无复发; 显效(18例): 头痛、 头晕等症状消失, 血压降至正常, 未 过半年复发; 有效 (6例): 头痛, 头暈减轻, 血压常波动在正常值和临界高血压的效 ( 5例): 症状时有减轻, 血压不降, 或降不到正常值范围。 总有效率 92%, 治愈率 71 %。  Efficacy criteria and results: 66 cases were observed for half a year, cured (47 cases): headache, dizziness symptoms disappeared, blood pressure decreased to normal, no recurrence after 6 months of follow-up; markedly effective (18 cases): headache, dizziness and other symptoms disappeared, blood pressure dropped to normal Recurrence within half a year; effective (6 cases): headache, dizziness, blood pressure, fluctuations in normal values and critical hypertension (5 cases): symptoms are relieved, blood pressure does not drop, or falls below normal range. The total effective rate is 92% and the cure rate is 71%.
(8)本发明所制成的功能体治疗冠心病 50例  (8) The functional body made by the invention treats 50 cases of coronary heart disease
、 临床资料 , clinical information
50例中, 男 37例, 女 13例; 年龄最大 76岁, 最小 23岁, 40- 49岁 8例, 50-59 岁 20例, 60-69岁 16例, 70- 79岁 3例。 西医临床分型, 心绞痛 17例, 其中稳定劳 力型心绞痛 16例, 不稳定型心绞痛 1例; 心律失常 15例, 其中室性早搏 10例, 房性 早搏 2例, 病窦综合征 1例, 房性纤颤 1例, 完全性右束支传导阻滞 1例; 心肌梗塞 9 例; 陈旧性心肌梗塞 11例。 中医临床分型, 属血瘀型 13例, 痰浊型 11例, 气滞型 8 例, 心气虚型 7例, 气阴两虚型 11例, 心阳虚型 5例。  Of the 50 patients, 37 were male and 13 were female; the oldest was 76 years old, the youngest was 23 years old, 8 cases were 40-49 years old, 20 cases were 50-59 years old, 16 cases were 60-69 years old, and 3 cases were 70-79 years old. Western medicine clinical classification, 17 cases of angina pectoris, including 16 cases of stable labor angina pectoris, 1 case of unstable angina pectoris; 15 cases of arrhythmia, including 10 cases of ventricular premature beats, 2 cases of premature atrial contraction, 1 case of sick sinus syndrome, room 1 case of fibrillation, 1 case of complete right bundle branch block; 9 cases of myocardial infarction; 11 cases of old myocardial infarction. The clinical classification of TCM was 13 cases of blood stasis type, 11 cases of turbidity type, 8 cases of qi stagnation type, 7 cases of qi deficiency type, 11 cases of qi and yin deficiency type, and 5 cases of heart yang deficiency type.
、 治疗方法 , treatment method
敏感点取穴以功能体特定穴位,心、心包经的俞募穴为主,配合八脉交会穴及心、 心包经郄穴, 第 1 组, 巨阙、 心俞、 膈俞、 内关、 公孙、 阴郄; 第二组, 膻中、 厥阴 俞、 三阴交、 郄门。 两组交替使用, 痰浊加太渊: 虚寒加膻中或膈俞。 Sensitive points take acupuncture points to the specific acupoints of the functional body, and the heart and the pericardium are mainly based on Yu's acupoints. Pericardium through the acupoints, group 1, giant scorpion, Xinshu, Yushu, Neiguan, Gongsun, yin; the second group, Suizhong, Yuyin Yu, Sanyinjiao, Tuen Mun. The two groups are used alternately, turbidity plus Taiyuan: deficient cold plus sputum or sputum.
用功能体治疗时, 将功能体贴在所选敏感点穴位上治疗 1 小时即可, 每天治疗 1 次, 10次为 1疗程, 一般观察 3个疗程。  When using functional body therapy, the functional body can be applied to the selected sensitive points for 1 hour, once a day, 10 times for a course of treatment, and generally observed for 3 courses.
疗效标准 1.心绞痛和心电图疗效标准根据 1979年全国《冠心病心绞痛及心电图疗 效评定标准》。 2.主要症状疗效标准 (包括胸闷痛、 心悸、 气短 3项): 显效为症状完 全消失或基本消失; 改善为症状程序明显减轻; 无效为症状与治疗前基本相同; 加重 为症状比治疗前加重。 3.血脂疗效标准根据 1974年上海复方丹参协作组制定的标准。  Efficacy criteria 1. The standard of angina pectoris and electrocardiogram was based on the National Standards for Assessment of Angina Pectoris and Electrocardiogram in 1979. 2. The main symptom efficacy criteria (including chest pain, palpitations, shortness of breath 3): markedly the symptoms disappeared completely or disappeared; improved as symptomatic procedures were significantly reduced; invalid symptoms were basically the same as before treatment; aggravated symptoms worsened than before treatment . 3. The standard of blood lipids is based on the standards set by the Shanghai Compound Danshen Collaborative Group in 1974.
治疗结果: ①各项主症的疗效(见表 1 )  Treatment results: 1 The efficacy of each main symptom (see Table 1)
②中医辨证分型的疗效(见表 2)  2 The efficacy of TCM syndrome differentiation (see Table 2)
③血脂疗效: 总胆固醇高 30例, 23例有效; 甘油三脂高 20例, 10例 有效。  3 blood lipid efficacy: total cholesterol was 30 cases, 23 cases were effective; triglyceride was high in 20 cases, 10 cases were effective.
表 1主症与疗效统计表  Table 1 main symptoms and efficacy statistics
主症 例数 显效 改善 无效 加重 有效率(%)  The number of main symptoms is markedly improved, invalid, aggravated, effective (%)
胸痛 30 20 6 2 2  Chest pain 30 20 6 2 2
胸闷 32 12 16 4 0 87. 50  Chest tightness 32 12 16 4 0 87. 50
心俸 23 10 8 5 0 78  Heart 俸 23 10 8 5 0 78
气短 13 5 7 1 0 92  Shortness of breath 13 5 7 1 0 92
表 2 中医辨证分型与疗效统计表  Table 2 TCM syndrome differentiation and efficacy statistics
分型 例数 显效 改善 无效  Number of cases, number of cases, improvement, invalid
血瘀 13 8 4 1  Bloody 13 8 4 1
痰浊 11 5 5 1  Turbidity 11 5 5 1
气滞 8 2 4 2  Gas lag 8 2 4 2
心气虚 7 3 3 1  Heart qi 7 3 3 1
气阴两虚 6 3 2 1  Qi and Yin deficiency 6 3 2 1
心阳虚 5 2 2 1  Heart yang 5 2 2 1
④心电图变化: 凡出现 ST-T改变, V波改变、 房颤、 病窦、 频发室性早搏、 频发房性早搏、 完全性右束支传 导阻不滞者都有所改善。  4 ECG changes: Where there is ST-T change, V wave changes, atrial fibrillation, sick sinus, frequent ventricular premature beats, frequent premature atrial contractions, complete right bundle branch conduction and conduction resistance are improved.
⑤心功能疗效:凡出现异常心功者,都有所乞讨善。结果 LVET延长, PEP, TICT缩短, PEP/LVET 之值减少。  5 heart function: Anyone who has abnormal heart function has a good deed. Results LVET prolonged, PEP, TICT shortened, and the value of PEP/LVET decreased.
(9)本发明所制成的功能体治疗老年性痴呆 76例  (9) Functional body made by the invention for treating 76 cases of senile dementia
一般资料  normal information
76例中男性 46例, 女性 30例; 年龄 59— 78岁, 平均 73岁; 病程 9个月一 8年, 平 均 2年 8个月。  There were 46 males and 30 females in 76 cases; the age ranged from 59 to 78 years old, with an average of 73 years; the course of disease was 9 months to 8 years, with an average of 2 years and 8 months.
治疗方法  treatment method
敏感点取穴百会、 四神聪、 大椎、 关元。 用本发明所制成的功能体, 将功能体治疗面 及穴位皮肤表面充分湿润后, 将功能体贴在所选敏感点穴位上, 再用松紧带或透气胶布固 定。头顶穴位则用增效膜固定。每次治疗 1小时, 每天 1次, 10次为 1疗程, 一般治疗 2-3 个月。 每疗程之间休息 2天。 治疗期间患者可继续用降压、 降脂、 降糖、 抗血小板聚集药 物。 Sensitive points are taken from Baihui, Sishencong, Dazhui and Guanyuan. After fully functionalizing the functional body surface and the acupoint skin surface with the functional body prepared by the invention, the functional body is attached to the selected sensitive point, and then the elastic band or the gas permeable adhesive cloth is used for fixing. Set. The acupuncture points on the head are fixed with a synergistic membrane. Each treatment for 1 hour, once a day, 10 times for a course of treatment, general treatment for 2-3 months. Rest 2 days between each course of treatment. Patients can continue to use antihypertensive, lipid-lowering, hypoglycemic, and anti-platelet aggregation drugs during treatment.
治疗效果  treatment effect
疗效判定标准: 基本痊愈: 症状消失, 生活自理, 能进行正常的社会交往活动; 显效: 症状改善, 但反应迟钝, 智力、 人格有障碍, 生活不能自理; 无效: 治疗前后无变化。  Efficacy criteria: Basic recovery: Symptoms disappear, self-care, can carry out normal social interaction activities; Significant effect: Symptoms improve, but slow response, mental and personality disorders, life can not take care of themselves; Ineffective: No change before and after treatment.
本组经治疗, 结果基本痊愈 7例, 显效 33例, 有效 26例, 无效 10例。 病程 <1年的 19例患者中 6例基本痊愈, 9例显效; 治疗无效者病程均〉 3年。 有效率为 86%。  After treatment, the results were basically cured in 7 cases, markedly effective in 33 cases, effective in 26 cases, and ineffective in 10 cases. Of the 19 patients with a course of <1 year, 6 were basically cured, 9 were markedly effective; those with ineffective treatment were all > 3 years. The effective rate is 86%.
( 10)本发明所制成的功能体治疗慢性肠炎 64例  (10) The functional body made by the invention treats 64 cases of chronic enteritis
1、 一般资料  1. General information
本组共 64例, 男 38例, 女 26例, 其中 30-40岁 8例, 41-50岁 18例, 51-60岁 26例,, 61岁以上 12例; 病程最短 1年, 最长 12年。 诊断依据: ①有急慢肠炎病史 或反复发作史; ②发病时, 出现腹泻、 腹痛等, 病人可出现慢性营养不良, 体格检查 可有腹部压痛, 大便常规可见白细胞、细胞及少量脓细胞。③ X线钡剂检查和结肠镜检 查排除其他非特异性肠道炎症。  There were 64 cases in this group, 38 males and 26 females, including 8 cases of 30-40 years old, 18 cases of 41-50 years old, 26 cases of 51-60 years old, and 12 cases of 61 years old and above; the shortest course was 1 year, the longest 12 years. Diagnosis basis: 1 history of acute inflammatory bowel disease or repeated episodes; 2 onset, diarrhea, abdominal pain, etc., patients may have chronic malnutrition, physical examination may have abdominal tenderness, white blood cells, cells and a small number of pus cells can be seen routinely. 3 X-ray barium examination and colonoscopy to exclude other non-specific intestinal inflammation.
2、 治疗方法  2, treatment
2. 1敏感点取穴 脐周四穴、 中脘、 天枢、 关元、 足三里、 上巨虚、 肾俞、 脾俞、 大肠俞、 曲池、 三阴交。  2. 1 Sensitive point acupoints Umbilical Week 4 points, Zhongmu, Tianshu, Guanyuan, Zusanli, Shangjuxu, Shenshu, Pishu, Dachangshu, Quchi, Sanyinjiao.
2. 2方法 将上穴分为二组。 第一组: 脐周四穴、 中脘、 天枢、 关元、 足三里、 上 巨虚、 合谷、 三阴交; 第二组: 脾俞、 肾俞、 大肠俞、 足三里、 上巨虚、 合谷。 两组 穴位每日轮流交替使用, 选用本发明功能体, 将其贴在所选敏感点穴位上, 每次 4-5 个穴位, 用透气胶带固定, 每次治疗 1小吋。 10次为 1个疗程。  2. 2 methods The upper holes are divided into two groups. The first group: Umbilical Thursday, Zhongmu, Tianshu, Guanyuan, Zusanli, Shangjuxu, Hegu, Sanyinjiao; Group 2: spleen, Shenshu, Dachangshu, Zusanli, Shangjuxu, Hegu . The acupuncture points of the two groups are alternately used every day. The functional body of the present invention is used, and it is attached to the acupuncture points of the selected sensitive points, 4-5 acupuncture points each time, and fixed by air-permeable tape, each treatment for 1 hour. 10 times for 1 course of treatment.
3、 治疗结果  3, treatment results
疗效标准 痊愈: 大便成形, 每日 1次; 好转: 大便成形, 每日 2次; 无效: 大 便治疗前后无明显改变。 64例中, 治愈 31例, 占 48. 4% ; 好转 28例, 占 43. 7 % ; 无 效 5例, 占 7. 9 %。 总有效率 92. 1 %。  Efficacy criteria Recovery: stool formation, 1 time a day; improved: stool formation, 2 times a day; Ineffective: no significant changes before and after treatment. Among the 64 cases, 31 cases were cured, accounting for 48.4%; 28 cases were improved, accounting for 43.7%, and 5 cases were ineffective, accounting for 7.9%. The total effective rate is 92. 1%.
( 11 )本发明所制成的功能体治疗慢性前列腺炎 68例疗效观察  (11) Therapeutic effect of 68 cases of chronic prostatitis treated by the functional body made by the invention
1、 临床资料  1. Clinical data
本组 68例, 多数患者曾接受中、 西医药物治疗。 年龄最小 17岁, 最大 76岁, 20 岁以下 3例, 21- 30岁 5例, 31- 40- 8例, 41- 50岁 17例, 50岁以上 35例; 病程最短 半年, 最长 20年。 已婚 57例, 未婚 11例。 大部分患者诉腰骶部酸胀, 小腹与会阴部 胀坠, 尿频, 排尿不畅, 淋沥不尽等症状, 其中 6例伴严重神经衰弱并性功能障碍。 前列腺液镜检: 白细胞 (+ ) 28例, (++) 21例, (+++) 15例, (++++) 4例。 其中前列腺肥大 32例, 前列腺结石 2例。  In this group of 68 patients, most patients have received Chinese and Western medicine treatment. The youngest is 17 years old, the largest is 76 years old, 3 cases are under 20 years old, 5 cases are 21- 30 years old, 31- 40- 8 cases, 17 cases are 41-50 years old, 35 cases are over 50 years old; the shortest course is half a year, the longest is 20 years . 57 were married and 11 were unmarried. Most patients complained of soreness in the lumbosacral region, swelling of the lower abdomen and perineum, frequent urination, poor urination, and incomplete leaching. Among them, 6 patients had severe neurasthenia and sexual dysfunction. Prostatic fluid microscopy: white blood cells (+) in 28 cases, (++) in 21 cases, (+++) in 15 cases, and (++++) in 4 cases. There were 32 cases of prostatic hypertrophy and 2 cases of prostatic stones.
2、 治疗方法  2, treatment
2. 1敏感点取穴  2. 1 sensitive point acupoint
主穴: 小肠俞、 膀胱俞、 脾俞、 次髎、 关元、 中极。 配穴: 阴陵泉、 三阴交、 太 溪。 实证加曲骨、 外关, 虚证加肾俞、 足三里。 Main points: small intestine Yu, bladder Yu, spleen, sputum, Guan Yuan, Zhongji. Matching points: Yinlingquan, Sanyinjiao, too Creek. Empirical plus bones, foreign customs, deficiency syndrome plus Shenshu, Zusanli.
2. 2操作  2. 2 operations
伏卧位所取穴用本发明功能体将其贴在所选敏感点穴位上, 用松紧带或透气胶布 固定, 每次治疗 1小时, 治疗后取下功能体即可。  The acupoints in the prone position are attached to the acupuncture points of the selected sensitive points by the functional body of the present invention, and are fixed by elastic bands or breathable tapes, and each treatment is performed for 1 hour, and the functional body can be removed after the treatment.
以上治疗每日 1次, 每次取主、 配穴 4-5个, 交替选用。 每 10天为一个疗程, 疗 程间休息 3-5天。  The above treatment is performed once a day, each time taking 4-5 of the main and matching points, and alternately selecting. A course of treatment every 10 days, rest 3-5 days between treatments.
、 疗效观察 Observation of curative effect
3. 1疗效标准  3. 1 efficacy standard
治愈: 自觉症状消失, 前列腺液镜检正常; 显效: 自觉症状基本消失, 前列腺液 高倍镜下白细胞不超过 3个; 好转: 自觉症状显著减轻, 前列腺液高倍镜下白细胞 4 - 6 个; 无效: 自觉症状及前列腺液检查均无明显改变。  Cure: Conscious symptoms disappear, prostatic fluid microscopy is normal; Significant effect: Conscious symptoms disappeared, no more than 3 white blood cells in prostatic fluid at high magnification; Improved: Significantly relieved symptoms, 4-6 of white blood cells in prostatic fluid at high magnification; Invalid: There were no significant changes in the symptoms and prostatic fluid tests.
3. 2治疗结果  3. 2 treatment results
68例经过 2- 3疗程后, 治愈 18例, 占 26. 55 ;显效 21例, 占 30. 9 % ; 好转 22例, 占 32. 3 % ; 无效 7例, 占 10. 3 %。 有效率为 89. 7 %。  After 68 cases of treatment, 68 cases were cured, accounting for 26.55; 21 cases were markedly effective, accounting for 30.99%; 22 cases were improved, accounting for 32.3 %; 7 cases were ineffective, accounting for 10.3%. The effective rate was 89.7 per cent.
不同年龄段患者疗效比较见表 1  Comparison of the efficacy of patients of different ages is shown in Table 1.
表 1不同年龄患者效比较  Table 1 Comparison of patient effects at different ages
年龄 例数 痊愈 显效 好转 无效 有效率 ( % )  Age number of cases, recovery, effectiveness, improvement, invalidity, efficiency (%)
17-20岁 3 1 2 - - - 17-20 years old 3 1 2 - - -
21-30岁 5 3 1 1 - -21-30 years old 5 3 1 1 - -
31-40岁 8 4 2 2 - -31-40 years old 8 4 2 2 - -
41-50岁 17 6 7 3 1 94. 1 41-50 years old 17 6 7 3 1 94. 1
50-76岁 35 4 9 16 6 82. 9  50-76 years old 35 4 9 16 6 82. 9
( 12 )本发明所制成的功能体治疗三叉神经痛 56例  (12) The functional body made by the invention treats 36 cases of trigeminal neuralgia
1、 临床资料  1. Clinical data
本组共治疗 56例, 其中男性 20例, 女性 36例; 年龄最大 78岁, 最小 35岁; 第 一支痛 5例, 第二支痛 15例, 第三支痛 16例; 复合型 20例; 病程最短 1个月, 最长 10余年; 原发性 48例、 继发性 8例。 其中胆脂瘤 3例, 疱疹后神经痛眼支 5例。 、 治疗方法  The group treated a total of 56 patients, including 20 males and 36 females; the oldest 78 years old, the youngest 35 years old; the first pain 5 cases, the second pain 15 cases, the third pain 16 cases; the composite type 20 cases The course of disease was as short as 1 month and the longest was more than 10 years; 48 cases were primary and 8 cases were secondary. There were 3 cases of cholesteatoma and 5 cases of post-herpetic neuralgia. , treatment method
敏感点取穴:第一支痛取鱼腰、下关为主,可配阳白、上星、合谷、内庭等穴。 二、 三支痛取四白、 下关、 地仓、 夹承浆、 合谷、 内庭等。 其中头面部穴位取患侧; 合谷、 内庭取双例。 贴本发明制成的功能体于敏感点穴位, 每日 1次, 10次为 1疗程, 休息 3-5天, 可继续下一疗程。  Sensitive points for acupoints: the first pain is taken from the waist of the fish, and the lower part is mainly used. It can be used with points such as Yangbai, Shangxing, Hegu, and Inner Court. Second, three pains take four white, Shimonoseki, the warehouse, the folder, the Hegu, the inner court and so on. The acupuncture points on the head and face are taken from the affected side; The functional body made by the invention is applied to the sensitive point, once a day, 10 times for a course of treatment, rest for 3-5 days, and the next course of treatment can be continued.
、 疗效观察 Observation of curative effect
疗效标准: 治疗后面部疼痛完全消失为临床治愈; 面部疼痛及发作次数显减少为 显效; 面部疼痛及发作次数减少为好转; 治疗后面部疼痛及发作次数无变化为无效。  Efficacy criteria: The treatment of the posterior part of the pain completely disappeared as a clinical cure; the facial pain and the number of episodes decreased significantly; the facial pain and the number of episodes decreased; the treatment of posterior pain and the number of episodes were not effective.
治疗结果: 本组病例中 38例患者就诊前曾口服卡马西平片, 因治疗一段时间后疗 效欠佳自行停止服药, 本发明制成的功能体治疗过程中未服药治疗。 18例未曾服药者 功能体治疗同时配合服用卡马西平片 0. lg, 每日 2次。 本发明制成的功能体治疗次数 最少 6次, 最多 20次。 临床治愈 42例, 占 75% ; 显效 9例, 占 16. 1 % ; 好转 5例, 占 8. 9% ; 无效 0例; 总有效率 100%。其中 42例随访半年内未复发, 11例分别在 3 - 4 个月内复发, 但症状较轻, 继续本发明功能体治疗 5- 10次后症状消失。 3例胆脂瘤患 者, 症状减轻后, 均转院手术治疗, 未追踪随访。 Treatment results: 38 patients in this group had oral carbamazepine tablets before treatment, and stopped taking the drug after treatment for a period of time. The functional body prepared by the present invention was not treated during the treatment. 18 patients who did not take the drug Functional body treatment with carbamazepine tablets 0. lg, 2 times a day. The functional body prepared by the present invention is treated at least 6 times and at most 20 times. 42 cases were cured clinically, accounting for 75%; 9 cases were markedly effective, accounting for 16.1%; 5 cases were improved, accounting for 8.9%; 0 cases were ineffective; the total effective rate was 100%. Among them, 42 cases had no recurrence within 6 months of follow-up, and 11 cases relapsed within 3 - 4 months, but the symptoms were mild. The symptoms disappeared after 5-10 treatments of the functional body of the present invention. Three patients with cholesteatoma were transferred to hospital for treatment after symptom reduction, and no follow-up was performed.
( 13) 本发明所制成的功能体治疗一般性头痛 120例  (13) 120 cases of general headache treated by the functional body made by the invention
、 临床资料 , clinical information
本组 120例患者中, 男 39例, 女 81例; 年龄最小 20岁, 最大 70岁; 病短 5小 时, 最长 20年。  Among the 120 patients in this group, 39 were male and 81 were female; the youngest was 20 years old and the oldest was 70 years old; the short illness was 5 hours and the longest was 20 years.
、 治疗方法 , treatment method
2. 1敏感点取穴 主穴为风池、 百会, 再根据临床辨证分型, 分别配以不同穴位。 临床上以外感型、 肝阳型及瘀血型多。 (1 )外感型: 头痛遇风而发, 痛势较剧。 配以 风府、 列缺、 外关、 合谷诸 穴。 (2)肝阳型: 头角掣痛, 多偏于一侧, 或连及巅顶, 配以四神聪 、 太冲、 水泉诸穴。 (3)瘀血型: 痛如锥刺, 经久不愈, 配以三阴交、 阿 是穴。  2. 1 Acupoints for sensitive points The main points are Fengchi and Baihui, and according to clinical syndrome differentiation, they are equipped with different acupoints. Clinically, there are many types of external sensation, liver yang and blood stasis. (1) Exogenous type: The headache is caused by the wind, and the pain is more dramatic. It is accompanied by Fengfu, Lie, Waiguan and Hegu. (2) Liver-yang type: The head horn is sore, mostly on one side, or even on the dome, with the points of Sishencong, Taichong and Shuiquan. (3) Blood type: pain such as cone thorn, long-term unhealed, with Sanyinjiao, Ashi points.
2. 2操作方法  2. 2 methods of operation
用本发明制成的功能体, 将其贴在所选敏感点穴位皮肤上, 用松带或透气胶带固 定, 每次治疗 1小时, 每天治疗 1次, 10次为 1疗程, 疗程间休息 2天, 1疗程后统 计疗效。  Use the functional body made by the invention, stick it on the skin of the selected sensitive point, fix it with loose band or breathable tape, treat it for 1 hour each time, treat once a day, 10 times for 1 course, rest during treatment 2 Days, statistical effects after 1 course of treatment.
、 疗效观察 Observation of curative effect
3. 1疗效标准 痊愈: 疼痛症状完全消失, 半年以上未复发者; 显效: 疼痛明显减 轻, 发作次数明显减少; 有效: 疼痛减轻, 发作次数较前减少; 无效: 治疗后疼痛症 状无改善。  3. 1 Efficacy criteria Healing: Pain symptoms disappear completely, no recurrence for more than half a year; Significant effect: Pain is significantly reduced, the number of seizures is significantly reduced; Effective: Pain is reduced, the number of seizures is reduced; Invalid: Pain symptoms are not improved after treatment.
3. 2治疗结果 120例患者中, 痊愈 96例, 占 80% ; 显效 18例, 占 15% ; 有效 6 例, 占 5%。 有效率 100%。  3. 2 Treatment results Among the 120 patients, 96 cases were cured, accounting for 80%; 18 cases were markedly effective, accounting for 15%; and 6 cases were effective, accounting for 5%. Effective 100%.
( 14)本发明所制成的功能体治疗胃、 十二指肠溃疡 50例  (14) The functional body made by the invention treats 50 cases of gastric and duodenal ulcer
、 对象与方法 , objects and methods
1. 1病例选择: 选所选的 80例住院患者, 均符合胃、 十二指肠溃疡诊断标准。 随 机分为两组, 治疗组 50例, 其中男 35例, 女 15例; 年龄 24-62岁, 平均(35. 5± 11. 3) 岁; 病程 0. 5- 20年, 平均 (6. 4±2. 8)年; 胃溃疡 19例, 十二指肠溃疡 26例, 复合型 溃疡 5例; 大例隐血试验阴性者 44例。 弱阳性者 4例, 阳性者 2例。 对照组 30例, 其 中男 18例, 女 12例; 年龄 20-68岁, 平均(34. 4± 12. 4)岁; 病程 4个月- 18年, 平均 (6. 5±3. 0)年; 胃溃疡 10例, 十二指肠溃疡 13例, 复合型溃疡 7例; 大便隐血试验 阴性者 25例, 弱阳性者 3例, 阳性者 2例。 两组经 X2统计学处理差异无显著性意义 (P>0. 05), 具有可比性。 1. 1 Case selection: The selected 80 hospitalized patients were in accordance with the diagnostic criteria for gastric and duodenal ulcers. They were randomly divided into two groups, 50 patients in the treatment group, including 35 males and 15 females; aged 24-62 years, mean (35. 5± 11. 3) years; disease duration 0. 5- 20 years, average (6. 4±2. 8) years; 19 cases of gastric ulcer, 26 cases of duodenal ulcer, 5 cases of compound ulcer; 44 cases of negative occult blood test. 4 cases were weakly positive and 2 cases were positive. 30 patients in the control group, including 18 males and 12 females; aged 20-68 years, mean (34.4 ± 12. 4) years; duration of disease 4 months - 18 years, average (6.5 ± 3. 0) Years; 10 cases of gastric ulcer, 13 cases of duodenal ulcer, 7 cases of compound ulcer; 25 cases of negative fecal occult blood test, 3 cases of weak positive, 2 cases of positive. There was no significant difference between the two groups by X 2 statistical treatment (P>0.05), which was comparable.
1. 2治疗方法: 治疗组敏感点取穴:第 1组取足三里、 内关、公孙;第 2组取中脘、 脾俞、 胃俞。 胃痛甚加梁丘, 胃寒甚加上下中脘, 腹胀甚加天枢, 反酸多加太冲, 便 秘加支沟, 失眠加神门, 乏力加气海。 以上两组穴位交替使用, 每日 1 次, 用本发明 制成的功能体, 将其贴在所选敏感点穴位上, 用透气胶带固定, 治疗 1小时, 10次为 1疗程。 2个月后后胃镜复査。对照组取穴: 取穴同上, 但使用普通针灸针平补泻手法。 溃疡出血(轻度)可辅助用药。 1. 2 treatment methods: treatment group sensitive points acupoints: the first group to take Zusanli, Neiguan, Gongsun; the second group to take Zhongyu, spleen, stomach Yu. Stomach pain is even more plus Liangqiu, stomach cold is added to the lower jaw, abdominal distension is even more Tianshu, acid reflux is too rushing, then Secret plus sulcus, insomnia plus the door, weak and refueling the sea. The above two groups of acupoints are used alternately, once a day, using the functional body made by the present invention, and sticking it on the selected sensitive point, and fixing it with air-permeable tape for 1 hour and 10 times for one course of treatment. After 2 months, the gastroscope was reviewed. Acupuncture points in the control group: The acupoints are the same as above, but the common acupuncture needles are used to replenish the diarrhea. Ulcer bleeding (mild) can aid medication.
1. 3观察项目: 溃疡面(以胃镜检査结果为标准), 部分临床症状(腹痛、 反酸)。 1. 4疗效评定标准:参照国家中医管理局 1994年颁发的《中医病症诊断疗效标准》。 临床治愈: 胃镜检査溃疡面已经愈合,临床症状消失或基本消失;显效:胃镜检査溃疡 面明显缩小或进入瘢痕期, 临床症状基本消失或明显减轻; 好转: 胃镜检查溃疡面未 缩小, 但胃粘膜充血水肿好转, 临床症状减轻; 无效: 治疗前后无变化(胃镜检查溃 疡面无改变, 临床症状无改善)。  1. 3 observation items: ulcer surface (with gastroscopy results as standard), some clinical symptoms (abdominal pain, acid reflux). 1. 4 Evaluation criteria for efficacy: Refer to the “Diagnostic and Efficacy Standards for TCM Disorders” issued by the State Administration of Traditional Chinese Medicine in 1994. Clinical cure: Gastroscopic examination of the ulcer surface has healed, clinical symptoms disappeared or disappeared; markedly effective: gastroscopic examination of the ulcer surface was significantly reduced or entered the scar period, clinical symptoms basically disappeared or significantly reduced; improved: gastroscopic examination of the ulcer surface did not shrink, but Gastric mucosal congestion and edema improved, clinical symptoms were alleviated; Ineffective: No change before and after treatment (no change in ulcerated surface by gastroscopy, no improvement in clinical symptoms).
、 结果  Result
见表 1、 2.  See Table 1, 2.
表 1两组疗效比较例  Table 1 Comparison of the two groups of efficacy
表 1 两组疗效比较  Table 1 Comparison of the two groups
组 别 例数 治愈 显效 好转 无效 总有效率(%)  Group number of cases, cure, effectiveness, improvement, invalid, total efficiency (%)
治疗组 50 14 11 21 4 92. 0°  Treatment group 50 14 11 21 4 92. 0°
对照组 30 6 6 13 5 83. 3  Control group 30 6 6 13 5 83. 3
表 2 两组治愈病例所需时间比较  Table 2 Comparison of time required for curing cases in both groups
组 别 例数 疗 程  Group number of treatments
6 7 8 9  6 7 8 9
治疗组 14 2 5 5 2  Treatment group 14 2 5 5 2
对照组 6 0 0 2 4  Control group 6 0 0 2 4
(15) 本发明所制成的功能体治疗血管性头痛 120例  (15) 120 cases of vascular headache treated by the functional body made by the invention
1、 临床资料  1. Clinical data
本组 120例中, 男 35例, 女 85例; 年龄最小 18岁, 最大 76岁, 病程最短 ld, 最长 10年。  In this group of 120 patients, 35 males and 85 females; the youngest is 18 years old, the largest is 76 years old, the shortest course is ld, the longest is 10 years.
2、 治疗方法  2, treatment
敏感点取穴: 分四组: 第 1组穴位: 印堂、 涌泉、 合谷; 第二组穴位: 印堂、 风池、 中 脘; 第三组穴位: 内关、 翳风、 太阳, 全头痛加发际四周穴; 第四组风池、 内关、 太阳、 率谷。  Acupoints for sensitive points: divided into four groups: the first group of points: Yintang, Yongquan, Hegu; The second group of points: Yintang, Fengchi, Zhongli; The third group of points: Neiguan, hurricane, sun, full headache plus Around the hair circle; the fourth group of wind pools, Neiguan, the sun, the rate valley.
方法: 用本发明制成的功能体, 将其贴在敏感点穴位表面, 用松紧带或透气胶布固定, 每次治疗 1小时, 10d为 1疗程, 疗程间休息 2d, 2个疗程后评定疗效。  Method: The functional body prepared by the invention is attached to the acupoint surface of the sensitive point, and fixed with an elastic band or a breathable adhesive tape. Each treatment is for 1 hour, 10 days is a course of treatment, and the treatment rests for 2 days, and the therapeutic effect is evaluated after 2 courses of treatment.
3、 疗效观察与结果  3, efficacy observation and results
临床治愈: 经治疗后, 疼痛消失, 恢复正常工作和生活, 随访半年无复发; 显效: 经治 疗后疼痛消失, 恢复正常工作和生活, 半年内复发; 有效: 经治疗后冬痛缓解, 劳累、 恼 怒加重, 时有复发; 无效: 经治疗后疼痛无缓解。  Clinical cure: After treatment, the pain disappears, return to normal work and life, no recurrence after 6 months of follow-up; markedly effective: After treatment, the pain disappears, return to normal work and life, relapse within half a year; Effective: After treatment, winter pain relieves, tired, When the anger is aggravated, there is a recurrence; Ineffective: The pain is not relieved after treatment.
120例中治愈 85例, 显效 20例, 有效 12例, 无效 3例, 总有效率达 97. 5%。 具体实施方式 Among the 120 cases, 85 cases were cured, 20 cases were markedly effective, 12 cases were effective, and 3 cases were ineffective. The total effective rate was 97.5%. detailed description
实施例 1  Example 1
所配制的高疗效功能复合材料的组成 (重量百分比) 为: 电气石超微粉 56%, 晶体红 外材料超微粉 40% (其中 Si02晶体 20%、 Si02晶体含量 >90%, MgO晶体 10%、 MgO晶体含量 >90%, AL203晶体 10%、 AL203晶体含量〉90%), 介导强化材料 2% (为合成正一壬酸香草酰 胺, 含量 70%), 包埋剂 2% (其中石蜡油 1%、 松香 1%) .其中电气石超微粉的粒径为 100 纳米, 晶体红外材料超微粉粒径为 500纳米。 The composition (weight percentage) of the prepared high-efficiency functional composite is: tourmaline ultrafine powder 56%, crystalline infrared material ultrafine powder 40% (including Si0 2 crystal 20%, Si0 2 crystal content >90%, MgO crystal 10%) , MgO crystal content >90%, AL 2 0 3 crystal 10%, AL 2 0 3 crystal content >90%), mediated strengthening material 2% (for synthesis of succinic acid vanillamide, 70% content), embedded 2% (including paraffin oil 1%, rosin 1%). The tourmaline ultrafine powder has a particle size of 100 nm, and the crystalline infrared material ultrafine powder has a particle size of 500 nm.
上述配料中, 电气石超微粉是从市场釆购优质电气石原矿, 经普通粉碎, 然后进行高 速球磨, 随后热处理。 高速球磨时间为 80小时, 热处理温度为 900°C, 保温时间为 2小时, 晶体红外材料是从市场购买经过普通粉碎的粉末原料, 经髙速球磨, 随后热处理。 高速球 磨时间为 50小时, 热处理温度为 800°C, 保温时间 2小时。  Among the above ingredients, tourmaline ultrafine powder is purchased from the market for high quality tourmaline ore, which is subjected to ordinary pulverization, followed by high speed ball milling and subsequent heat treatment. The high-speed ball milling time is 80 hours, the heat treatment temperature is 900 ° C, and the holding time is 2 hours. The crystal infrared material is purchased from the market through ordinary pulverized powder raw materials, subjected to idle ball milling, and then heat treated. The high-speed ball milling time is 50 hours, the heat treatment temperature is 800 ° C, and the holding time is 2 hours.
上述配料投入 V型混料混合机中, 充分搅拌, 使之混合充分均勾后, 将其置于密封恒 温干燥箱, 进行加温处理, 加温温度为 140°C, 保温时间 1天, 即成为高疗效功能复合粉体 材料, 用于人体的保健、 康复、 治疗与提高生活质量用途。  The above ingredients are put into the V-type mixing mixer, fully stirred, mixed and fully hooked, placed in a sealed constant temperature drying oven, and heated, the heating temperature is 140 ° C, and the holding time is 1 day, ie It is a high-efficiency functional composite powder material for human health care, rehabilitation, treatment and quality of life.
该实施例 1, 其中的介导强化剂材料 2%, 为较弱强度, 用于人体比较敏感的穴位治疗, 如神阙穴(脐中) 治疗或者头颈部穴位治疗。  In the embodiment 1, the intensive enhancer material is 2%, which is a weaker strength, and is used for acupuncture treatments sensitive to the human body, such as Shenque (umbilical) treatment or acupuncture treatment of head and neck.
实施例 2  Example 2
所配制的高疗效功能复合材料的组成 (重量百分比) 为: 电气石超微粉 55%, 晶体红 外材料超微粉 40% (其中 Si02晶体 20%、 Si02晶体含量〉 90%, MgO晶体 10%、 MgO晶体含 量〉 90%, AL203晶体 10%、 AL203晶体含量〉 90%,), 介导强化材料 3% (为合成正一壬酸香 草酰胺, 含量 70%), 包埋剂 2.0% (其中石蜡油 1%、 松香 1.0%), 其中电气石超微粉的粒 径为 90纳米, 晶体红外材料超微粉粒径为 450纳米。 High efficacy functional composition formulated composite material (by weight) of: 55% ultrafine tourmaline, 40% crystalline superfine infrared materials (including crystals Si0 2 20%, Si0 2 crystal content> 90%, MgO 10% crystalline , MgO crystal content > 90%, AL 2 0 3 crystal 10%, AL 2 0 3 crystal content > 90%,), mediated strengthening material 3% (for the synthesis of n-antimonic acid vanillamide, 70%), package The embedding agent is 2.0% (including paraffin oil 1%, rosin 1.0%), wherein the tourmaline ultrafine powder has a particle size of 90 nm, and the crystalline infrared material ultrafine powder has a particle size of 450 nm.
上述配料中, 电气石超微粉是从市场采购的电气石原矿, 先作普通粉碎, 然后加入高 速球磨机球磨, 随后进行热处理。 高速球磨时间为 80小时, 热处理温度为 900'C, 保温时 间为 2 小时, 晶体红外材料是从市场购买的普通粉末原料, 亦加入高速球磨机球磨, 随后 热处理。 球磨时间为 50小时, 热处理温度为 800°C, 保温时间 2小时。  Among the above ingredients, tourmaline ultrafine powder is a tourmaline ore originally purchased from the market, which is firstly pulverized, then added to a high speed ball mill ball mill, followed by heat treatment. The high-speed ball milling time is 80 hours, the heat treatment temperature is 900'C, and the heat preservation time is 2 hours. The crystal infrared material is a common powder raw material purchased from the market, and is also added to a high-speed ball mill ball mill, followed by heat treatment. The ball milling time was 50 hours, the heat treatment temperature was 800 ° C, and the holding time was 2 hours.
上述配料除粘结剂外, 投入 V型混料混合机中, 作混合搅拌, 使之充分混合均勾后, 将其置于密封恒温干燥箱, 进行加温处理, 加温温度为 150°C, 保温时间 2天。  In addition to the binder, the above ingredients are put into a V-type mixing mixer, mixed and stirred, and then fully mixed and hooked, placed in a sealed constant temperature drying oven, and subjected to heating treatment at a heating temperature of 150 ° C. , holding time 2 days.
再按总重量的 3%称取粘结剂 (其中硬脂酸 1. 5%、 聚氯乙烯 1. 5%), 将前述制好的粉体 与粘结剂再投入混料机, 充分混合均匀。  Then weighed 3% of the total weight (including 1.5% of stearic acid and 1.5% of polyvinyl chloride), and then put the prepared powder and binder into the mixer and mix well. Evenly.
将上述工艺制备的粉体装入八角型模具中,在压力机上压制成八角形片状,其直径 3cm, 厚度 0. 3cm, 压制力为 24Mpa。  The powder prepared by the above process was placed in an octagonal mold, and pressed into an octagonal sheet shape on a press having a diameter of 3 cm, a thickness of 0.3 cm, and a pressing force of 24 MPa.
所制备的片状硬固体物即为高疗效功能复合硬固体材料, 可用于人体保健与慢性病的 康复治疗器械与器材。  The prepared sheet-like hard solid is a high-efficiency functional composite hard solid material, which can be used for rehabilitation equipment and equipment for human health and chronic diseases.
该实施例 2所制成的高疗效功能复合硬固体材料可以制成上述临床疗效中所使用的硬 固体功能片。上述临床疗效中所使用的硬固体功能片可为上述制成的八角形片状,直径 3cm, 厚度 0.3cm。 该实施例 2,其中的介导强化剂材料 3%, 为稍强的强度,用于人体一般敏感穴位治疗, 如躯体穴位治疗。 The high-efficiency functional composite hard solid material prepared in this Example 2 can be used as a hard solid functional tablet used in the above clinical effects. The hard solid functional sheet used in the above clinical effects may be in the form of an octagonal sheet prepared as described above, having a diameter of 3 cm and a thickness of 0.3 cm. In the second embodiment, the 3% of the reinforcing agent material is a slightly stronger strength, and is used for the general sensitive acupoint treatment of the human body, such as body acupoint treatment.
实施例 3  Example 3
所配制的髙疗效功能复合材料的组成 (重量百分比) 为: 电气石超微粉 52%, 晶体红 外材料超微粉 40% (其中 Si02晶体 20%、 Si02晶体含量〉 90°/。, MgO晶体 10%、 MgO晶体含量 >90%, AL203晶体 10%、 AL203晶体含量〉 90%), 介导强化材料 5% (为合成正一壬酸香草酰 胺, 含量 70%), 包埋剂 3% (其中石蜡油 1.5%、 松香 1.5%) .其中电气石超微粉的粒径为 80纳米, 晶体红外材料超微粉粒径为 500纳米。 The composition (weight percentage) of the prepared sputum therapeutic functional composite is: tourmaline ultrafine powder 52%, crystalline infrared material ultrafine powder 40% (where SiO 2 crystal 20%, Si0 2 crystal content > 90 ° /., MgO crystal 10%, MgO crystal content >90%, AL 2 0 3 crystal 10%, AL 2 0 3 crystal content >90%), mediated strengthening material 5% (for the synthesis of n-carboxamide, 70%) The embedding agent is 3% (including paraffin oil 1.5%, rosin 1.5%). The tourmaline ultrafine powder has a particle size of 80 nm, and the crystalline infrared material ultrafine powder has a particle size of 500 nm.
上述配料中, 电气石超微粉是从市场购电气石原矿, 经普通粉碎, 再入高速球磨机球 磨, 随后热处理。 球磨时间为 80小时, 热处理温度为 900°C, 保温时间 2小时, 晶体红外 材料是从市场购买后, 再经高速球磨, 随后热处理。 高速球磨时间为 50小时, 热处理温度 为 800V, 保温时间 2小时。  Among the above ingredients, tourmaline ultrafine powder is purchased from the market for tourmaline ore, which is subjected to ordinary pulverization, and then into a high-speed ball mill for ball milling, followed by heat treatment. The ball milling time is 80 hours, the heat treatment temperature is 900 ° C, and the holding time is 2 hours. The crystal infrared material is purchased from the market, then subjected to high-speed ball milling, followed by heat treatment. The high-speed ball milling time is 50 hours, the heat treatment temperature is 800V, and the holding time is 2 hours.
上述配料投入混料机中, 充分搅拌, 使之混合充分均匀后, 再将其置于密封的恒温干 燥箱, 进行加温处理, 加温温度为 150°C, 保温时间 2天.  The above ingredients are put into the mixer, fully stirred, and mixed thoroughly, and then placed in a sealed constant temperature drying box for heating treatment, the heating temperature is 150 ° C, and the holding time is 2 days.
取上述工艺生产的粉体原料 50重量%, 另取合成橡胶粉 50重量%, 投入橡胶混合机中, 将高疗效功能复合粉体与橡胶粉体充分混合, 按普通橡胶工艺加工成为高疗效功能复合橡 胶泥。 所制配的复合橡胶泥即为高疗效功能复合软固体材料, 可用于人体保健与慢性疾病 康复治疗器械与器材以及美容美体等提高生活质量用途。  Take 50% by weight of the powder raw material produced by the above process, and take 50% by weight of the synthetic rubber powder, put it into the rubber mixer, mix the high-efficiency functional composite powder with the rubber powder, and process it into a high-efficiency function according to the ordinary rubber process. Composite rubber mud. The compounded rubber mud is a high-efficiency functional composite soft solid material, which can be used for human health care and chronic diseases, rehabilitation equipment and equipment, and beauty and body to improve the quality of life.
该实施例 3, 其中的介导强化剂材料 5%, 为较强的强度, 用于人体不太敏感的穴位治 疗, 如四肢肢体穴位治疗。  In the third embodiment, the 5% of the reinforcing agent material is a strong intensity, and is used for acupoint treatment of the human body, such as limb acupoint treatment.
该实施例 3所制成的高疗效功能复合软固体材料可以制成上述临床疗效中所使用的功 能体。 上述临床疗效中所使用的功能体的为圆形片状, 直径 3cm, 厚度 0.2-0.3cm。  The high-efficiency functional composite soft solid material prepared in this Example 3 can be used as the functional body used in the above clinical effects. The functional body used in the above clinical effects is a circular sheet having a diameter of 3 cm and a thickness of 0.2 to 0.3 cm.
实施例 4 Example 4
所配制的高疗效功能复合材料的组成 (重量百分比) 为电气石超微粉 60%, 晶体红外 材料超微粉 35% (其中 AL203 20%,含量〉 90%, MgO 15%,含量〉 90%; ), 介导强化剂 0, 5% (为 合成正一壬酸香草酰胺, 含量 70%), 包埋剂 4. 5% (其中石蜡油 1%, 松香 1%, 甲基纤维素 2. 5%)。 其中电气石超微粉的平均粒径为 125纳米, 晶体红外材料超微粉粒径平均为 500纳 米。 The composition (weight percentage) of the formulated high-efficiency functional composite is 60% of tourmaline ultrafine powder, and 35% of crystalline infrared material ultrafine powder (including AL 2 0 3 20%, content > 90%, MgO 15%, content > 90) %; ), mediated enhancer 0, 5% (for synthesizing n-citric acid vanillamide, 70%), embedding agent 4.5% (including paraffin oil 1%, rosin 1%, methyl cellulose 2) .5%). The average particle size of the tourmaline ultrafine powder is 125 nm, and the ultrafine particle size of the crystalline infrared material is 500 nm on average.
上述配料中, 电气石超微粉是从市场采购优质电气石原矿, 经普通粉碎, 然后进行高 速球磨, 随后热处理。 高速球磨时间为 80小时, 热处理温度为 950°C, 保温时间为 2小时。 晶体红外材料是从市场购买经过普通粉碎的粉末原料, 经高速球磨, 随后热处理。 高速球 磨时间为 56小时, 热处理温度为 850°C, 保温时间 2小时。  Among the above ingredients, tourmaline ultrafine powder is purchased from the market for high quality tourmaline ore, which is subjected to ordinary pulverization, followed by high speed ball milling and subsequent heat treatment. The high-speed ball milling time is 80 hours, the heat treatment temperature is 950 ° C, and the holding time is 2 hours. The crystal infrared material is purchased from the market through ordinary pulverized powder raw materials, subjected to high speed ball milling, and then heat treated. The high-speed ball milling time is 56 hours, the heat treatment temperature is 850 ° C, and the holding time is 2 hours.
上述配料投入 V型混料混合机中, 作混合搅拌, 使之充分混合均勾, 将其置于密封恒 温干燥箱, 进行加温处理, 加温温度为 15(TC, 保温时间 1天。 即成为高疗效复合功能粉体 材料。  The above ingredients are put into a V-type mixing mixer, mixed and stirred, and fully mixed and hooked, placed in a sealed constant temperature drying oven, and subjected to heating treatment, and the heating temperature is 15 (TC, holding time is 1 day. Become a high-efficiency composite functional powder material.
按重量百分比, 用上述加工的髙疗效功能复合材料之粉体材料 50重量%, 另加入 50重 量%软固体基质材料 (液状树脂), 置于匀浆机内充分搅拌混合均匀, 再用真空泵泵入圆形 片模具, 加温固化(固化加温温度 180°C )成型, 即成为高疗效功能材料软体片, 用于人体 的乳中穴等特敏感穴位治疗, 康复疾病与提高生活质量。 According to the weight percentage, 50% by weight of the powder material of the above-mentioned processed 髙 therapeutic functional composite, 50% by weight of soft solid matrix material (liquid resin), placed in the homogenizer, thoroughly stirred and mixed, and then vacuum pump Into the circle The film mold is heated and solidified (curing temperature is 180 °C), which becomes a high-effect functional material soft film, which is used for the treatment of special sensitive acupoints such as milk in the human body, to recover diseases and improve the quality of life.
实施例 5 Example 5
所配制的高疗效功能复合材料的组成(重量百分比) 为电气石超微粉 40%, 晶体红外 材料超微粉 30% (AL203 30%,含量〉 90%), 介导强化剂 28% (为合成正一壬酸香草酰胺, 含量 70%), 包埋剂 2% (其中石蜡油 1%, 松香 1%), 其中电气石超微粉的平均粒径为 120纳米, AL203微粉平均粒径为 1微米。 The composition (weight percentage) of the formulated high-efficiency functional composite is 40% of tourmaline ultrafine powder, 30% of crystalline infrared material ultrafine powder (AL 2 0 3 30%, content > 90%), and 28% of intensive enhancer ( For the synthesis of n-antimonic acid vanillamide, 70%), embedding agent 2% (including paraffin oil 1%, rosin 1%), wherein the tourmaline ultrafine powder has an average particle size of 120 nm, AL 2 0 3 micropowder average The particle size is 1 micron.
上述配料中, 电气石超微粉是从市场采购的电气石原矿, 先作普通粉碎, 然后投入高 速球磨机球磨, 随后进行热处理。 高速球磨时间为 80小时, 热处理温度为 950Ό , 保温时 间为 2小时。 AL203为市场购买粉体, 粉体粒径平均 1微米左右, 对其进行热处理, 热处理 温度为 800°C, 保温时间 2小时。 Among the above ingredients, tourmaline ultrafine powder is a tourmaline ore originally purchased from the market, which is firstly pulverized and then put into a high-speed ball mill ball mill, followed by heat treatment. The high-speed ball milling time is 80 hours, the heat treatment temperature is 950 Ό, and the holding time is 2 hours. AL 2 0 3 is a powder purchased from the market. The powder has an average particle size of about 1 micrometer and is heat-treated at a heat treatment temperature of 800 ° C for 2 hours.
将以上加工的粉体和介导强化剂 、 包埋剂投入 V型混料混合机中, 作混合搅拌, 使之 充分混合均匀, 将其置于密封恒温干燥箱, 进行加温处理, 加温温度为 150Ό , 保温时间 2 天。 即成为高疗效复合功能粉体材料。  The above processed powder, medium-intensifying agent and embedding agent are put into a V-type mixing mixer, mixed and stirred, and thoroughly mixed, and placed in a sealed constant temperature drying oven for heating treatment and heating. The temperature is 150 Ό and the holding time is 2 days. It becomes a high-efficiency composite functional powder material.
按重量百分比, 用上述加工的高疗效功能复合材料之粉体材料 50重量 ¾>, 另加入 50重 量%软固体基质材料 (液状树脂), 置于匀浆机内充分搅拌混合均匀, 再用真空泵泵入圆形 片模具, 加温固化 (固化加温温度 180°C )成型, 即成为高疗效功能材料超强软体功能片, 用于人体足部如涌泉穴等特不敏感穴位治疗, 康复疾病与提高生活质量。  According to the weight percentage, 50 parts by weight of the above-mentioned processed high-efficiency functional composite powder material, and 50% by weight of soft solid matrix material (liquid resin), placed in a homogenizer, thoroughly stirred and mixed, and then vacuum pump Pumped into a circular die, heated and cured (curing temperature is 180 °C), it becomes a super-soft functional film for high-efficiency functional materials, which is used for treatment of special acupoints such as Yongquan acupoints in human foot, rehabilitation Disease and improve the quality of life.
工业上的应用性 Industrial applicability
本发明的髙疗效功能复合材料可以是粉体材料、 硬固体材料、 软固体材料, 可用于人 体保健与慢性疾病康复治疗器械与器材以及美容美体等提高生活质量用途。用于治疗学生脑 疲劳、治疗学习困难儿童、控制海洛因依赖戒断症状、 治疗眩晕、 治疗中风后遗症、 治疗便 秘型肠易激综合征、 治疗高血压病、 治疗冠心病、 治疗老年性痴呆、 治疗慢性肠炎、 治疗 慢性前列腺炎、 治疗三叉神经痛、 治疗一般性头痛、 治疗胃、 十二指肠溃疡等的应用, 并 且效果显著。  The therapeutic effect functional composite of the present invention may be a powder material, a hard solid material or a soft solid material, and can be used for improving the quality of life of human health care and chronic disease rehabilitation treatment equipment and equipment, and beauty and body. It is used to treat students' brain fatigue, treat children with learning difficulties, control heroin dependence withdrawal symptoms, treat dizziness, treat stroke sequelae, treat constipation irritable bowel syndrome, treat hypertension, treat coronary heart disease, treat senile dementia, treat Chronic enteritis, treatment of chronic prostatitis, treatment of trigeminal neuralgia, treatment of general headache, treatment of stomach, duodenal ulcer, etc., and the effect is remarkable.

Claims

1、一种高疗效功能复合材料, 其特征是由下述重量百分比原料复合制成: 电气石超微 粉和 /或晶体红外材料超微粉 66-96% 1. A high-efficiency functional composite material characterized by being compounded by the following weight percentages of raw materials: tourmaline ultrafine powder and/or crystalline infrared material ultrafine powder 66-96%
介导强化材料 0.01-30%  Mediated strengthening material 0.01-30%
包埋剂 1-5%。  The embedding agent is 1-5%.
2、 根据权利要求 1所述的复合材料, 其特征是所述电气石是一种具有永久电极的硅酸 盐天然矿物, 是选自铁电气石、 镁电气石、 铁镁电气石、 锂电气石等电气石中的一种或几 种, 粒径〈5微米; 所述的晶体红外材料选自 AL203、 Si02、 MgO、 Ti02等氧化物晶体的一种 或几种,粒径〈500微米;所述的介导强化材料是一种含香草酰胺的生物碱,化学名为 N- (4- 羟基 -3-甲氧基苄基) -8-甲基壬-反 -6-稀酰胺及其同系类似物和衍生物化合物单体之一种或几 种, 可以是天然提取或人工合成, 包括但不限于壬酸香草酰胺; 所述包埋剂为石蜡油、 松 香、 甲基纤维素任一种或任两种之和。 2. The composite material according to claim 1, wherein the tourmaline is a silicate natural mineral having a permanent electrode selected from the group consisting of iron tourmaline, magnesium tourmaline, iron-magnesium tourmaline, and lithium electrical. One or more of stone and other tourmaline, particle size <5 microns; the crystalline infrared material is selected from one or more of oxide crystals such as AL 2 0 3 , Si0 2 , MgO, Ti0 2 , etc. The diameter of the <500 micrometer; the mediated strengthening material is a vanillamide-containing alkaloid, the chemical name is N-(4-hydroxy-3-methoxybenzyl)-8-methylindole-anti-6 - one or more of a dilamide and its homologous analog and derivative compound monomers, which may be natural or synthetic, including but not limited to vanillin citrate; the embedding agent is paraffin oil, rosin, nail Any one or a combination of two of the celluloses.
3、 一种权利要求 1或权利要求 2所述的高疗效功能复合材料的制造方法, 其特征在于 包括如下工艺步骤:  3. A method of manufacturing a high-efficiency functional composite according to claim 1 or claim 2, comprising the following process steps:
( 1 )按照权利要求 1或权利要求 2所述的高疗效功能复合材料组成的重量百分比配料; (1) A weight percentage ingredient consisting of the high-efficiency functional composite according to claim 1 or claim 2;
(2)将电气石超微粉和 /或晶体红外材料超微粉分别进行热处理,热处理温度 300-1000 V, 保温时间 1-5小时; (2) heat treatment of tourmaline ultrafine powder and/or crystalline infrared material ultrafine powder separately, heat treatment temperature 300-1000 V, holding time 1-5 hours;
(3)将全部配料入混料机中搅拌混合, 使之充分混合均匀;  (3) Mix and mix all the ingredients into the mixer to make them fully mixed;
(4) 将混合充分均匀原料置于密封的恒温干燥箱进行加温处理, 加温温度为 60-200 V, 保温时间 1-3天, 即成为高疗效功能复合材料之粉体材料。  (4) The mixed and well-mixed raw materials are placed in a sealed constant temperature drying oven for heating treatment. The heating temperature is 60-200 V, and the holding time is 1-3 days, which becomes the powder material of the high-efficiency functional composite material.
4、 根据权利要求 1或权利要求 2所述的高疗效复合材料的制造方法, 其特征在于还包 括如下工艺步骤- 4. A method of manufacturing a high-efficiency composite material according to claim 1 or claim 2, further comprising the following process steps -
(5)用 20- 60重量%的高疗效功能复合材料之粉体材料, 40- 80重量%的软固体基质材 料进行高疗效功能复合材料之软固体材料配料; (5) using 20-60% by weight of the high-effect functional composite powder material, 40-80% by weight of the soft solid matrix material for the soft solid material formulation of the high-efficiency functional composite;
(6)根据软固体基质材料特性进行上述配料的混合、 加工成形, 即为高疗效功能复合 材料之软固体材料。  (6) The mixing and processing of the above ingredients according to the characteristics of the soft solid matrix material, that is, the soft solid material of the high-efficiency functional composite material.
5、 根据权利要求 4所述的高疗效复合材料制造方法, 其特征在于软固体基质材料为天 然或合成橡胶粉或其他软固体基质材料的一种或几种。  5. A method of making a high-potency composite according to claim 4, wherein the soft solid matrix material is one or more of natural or synthetic rubber powder or other soft solid matrix material.
6、 根据权利要求 1或权利要求 2所述的高疗效复合材料的制造方法, 其特征在于还包 括如下工艺步骤: (5 ) ' 在高疗效功能复合粉体材料之粉体材料中, 加入相对于高疗效功能复合粉体材 料之粉体材料的 1-5重量%的粘结剂, 再加入混料机充分混合均匀; 6. The method of manufacturing a high-efficiency composite material according to claim 1 or claim 2, further comprising the following process steps: (5) 'In the powder material of the high-efficiency functional composite powder material, 1-5 wt% of the binder relative to the powder material of the high-efficiency functional composite powder material is added, and then mixed well by adding the mixer. Uniform
(6) ' 将上述混合物置于有一定形状的模具中, 放在压力机上施压, 压力为 12- 30Mpa, 将其压制成形, 即成高疗效功能复合材料之硬固体材料。  (6) 'The above mixture is placed in a mold with a certain shape, pressed on a press, and the pressure is 12-30 Mpa, which is press-formed into a hard solid material of a high-efficiency functional composite.
7、 根据权利要求 6所述的高疗效复合材料的制造方法, 其特征于粘结剂为亚麻油、 蓖 麻油、 硬脂酸、 聚氯乙烯、 松脂中的任一种或任两种之和。  The method for producing a high-efficiency composite material according to claim 6, wherein the binder is any one of linseed oil, castor oil, stearic acid, polyvinyl chloride, rosin, or a combination of any two .
8、 一种权利要求 1或权利要求 2所述的高疗效功能复合材料的应用, 其特征在于可用 于人类保健、 治疗与康复领域。  8. Use of a high efficacy functional composite according to claim 1 or claim 2, which is useful in the field of human health, treatment and rehabilitation.
9、 根据权利要求 8所述髙疗效功能复合材料的应用, 其特征在于是在人体体表面敏感 点 (穴位) 治疗, 通过内病外治, 有效治疗各种非感染性、 非营养性的慢性疾病和提高生 活质量。  9. The use of the therapeutic effect functional composite according to claim 8, characterized in that it is treated at a sensitive point (acupoint) on the surface of the human body, and is effective for treating various non-infectious, non-nutritional chronic diseases by internal disease treatment. Disease and improve the quality of life.
10、 根据权利要求 8或权利要求 9所述的高疗效功能复合材料的应用, 其特征于制成 各种无源医疗器材与器械及其他医疗用品、 纺织品、 日用品等, 替代针灸、 药物治疗与有 源器械康复与治疗疾病和提高生活质量。  10. The use of a high-efficiency functional composite according to claim 8 or claim 9, characterized in that it is made into various passive medical devices and instruments and other medical supplies, textiles, daily necessities, etc., instead of acupuncture, medical treatment and Active devices rehabilitate and treat diseases and improve quality of life.
PCT/CN2007/001244 2006-04-17 2007-04-16 A functional composite material with good curative effect and preparation, uses thereof WO2007118430A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200610072266.2 2006-04-17
CN2006100722662A CN101057980B (en) 2006-04-17 2006-04-17 High efficient functional composite material and its preparation method and application

Publications (1)

Publication Number Publication Date
WO2007118430A1 true WO2007118430A1 (en) 2007-10-25

Family

ID=38609070

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2007/001244 WO2007118430A1 (en) 2006-04-17 2007-04-16 A functional composite material with good curative effect and preparation, uses thereof

Country Status (2)

Country Link
CN (1) CN101057980B (en)
WO (1) WO2007118430A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103316014A (en) * 2008-08-13 2013-09-25 杨孟君 Specific acupuncture function composite material, preparation method thereof and applications
CN102441191A (en) * 2010-09-30 2012-05-09 杨孟君 Novel medical composite material, preparation method thereof, and purpose thereof
CN104586818A (en) * 2013-11-01 2015-05-06 北京中卫神农慢性病医学研究院有限公司 Micro-porous capsicine sustained-release apparatus
CN104027242B (en) * 2014-07-09 2017-06-30 姜兴鹏 Its moxibustion pot
CN108785084A (en) * 2017-05-05 2018-11-13 杨孟君 A kind of orientation Chinese medicine target tank
CN109646293A (en) * 2017-10-12 2019-04-19 杨孟君 It takes advantage of a situation acupuncture apparatus

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910512A (en) * 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
CN1293278A (en) * 2000-11-16 2001-05-02 戴彦彤 Health-care far infrared and negative oxygen ion fabric and its preparing process
CN1360094A (en) * 2000-12-22 2002-07-24 上海惠尔婷高级内衣有限公司 Warming and health-care photoelectronic fibres and preparing process thereof
CN1360093A (en) * 2000-12-21 2002-07-24 上海惠尔婷高级内衣有限公司 Health-care anionic fibre and its preparing process
CN1635045A (en) * 2004-12-24 2005-07-06 安泰科技股份有限公司 Complex with self heat accumulation function, its preparation and use thereof
CN2725091Y (en) * 2004-09-02 2005-09-14 翁觅离 Cushion for automobile

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910512A (en) * 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
CN1293278A (en) * 2000-11-16 2001-05-02 戴彦彤 Health-care far infrared and negative oxygen ion fabric and its preparing process
CN1360093A (en) * 2000-12-21 2002-07-24 上海惠尔婷高级内衣有限公司 Health-care anionic fibre and its preparing process
CN1360094A (en) * 2000-12-22 2002-07-24 上海惠尔婷高级内衣有限公司 Warming and health-care photoelectronic fibres and preparing process thereof
CN2725091Y (en) * 2004-09-02 2005-09-14 翁觅离 Cushion for automobile
CN1635045A (en) * 2004-12-24 2005-07-06 安泰科技股份有限公司 Complex with self heat accumulation function, its preparation and use thereof

Also Published As

Publication number Publication date
CN101057980B (en) 2012-07-04
CN101057980A (en) 2007-10-24

Similar Documents

Publication Publication Date Title
World Health Organization Acupuncture: review and analysis of reports on controlled clinical trials
Daquin et al. Yawning
Ellingwood American Materia Medica, Therapeutics and Pharmacognosy: Developing the Latest Acquired Knowledge of Drugs, and Especially of the Direct Action of Single Drugs upon Exact Conditions of Disease, With Especial Reference to the Therapeutics of the Plant Drugs of the Americas
WO2007118430A1 (en) A functional composite material with good curative effect and preparation, uses thereof
JP5015165B2 (en) Manufacture and use of medical devices for rehabilitation of chronic diseases in alternative therapies
Grinspoon et al. Psychedelics as catalysts of insight-oriented psychotherapy
KEITNER et al. Spontaneous ejaculations and neuroleptics
CN107320674A (en) A kind of Chinese medicine composition and its application
CN104473519B (en) A kind of medicinal pillow improved and keep memory ability
US8936815B2 (en) Device for external use in alternative medicine applications
CN103330898B (en) Traditional Chinese medicine composition for curing impotence and prospermia, as well as preparation method and application of traditional Chinese medicine composition
CN102813888B (en) Chinese herbal composition for treating epilepsy
CN107080786A (en) Antidepressant compositions and its preparation method and application and medicine or pharmaceutical composition comprising it
CN103239625A (en) Traditional Chinese medicinal preparation for treating facial paralysis
CN110279691A (en) A kind of surgical postoperative nursing analgesic and application thereof
Zhang et al. Efficacy observation on Governor Vessel-regulating and brain-unblocking acupuncture for post-stroke depression
TW201121562A (en) Compositions of Clerodendrum sp. for treating tic disorders or psychiatric disorders with sensorimotor gating deficits
CN104138453B (en) A kind of Chinese medicine preparation treating facial nerve paralysis
PERLSTEIN et al. Neostigmine therapy in cerebral palsy: A critical evaluation
Husain Homeopathy in Practice: Clinical Insights into Homeopathy & Remedies
Sukariada et al. The Effectivity of Ethanol Extract of Datura Metel L. Seeds as a General Anaesthesia on Kintamani Dogs
Tan et al. Clinical observation on Nie-pinching spine manipulation combined with point therapy for cerebral palsy in children with spleen deficiency
Srbely et al. NEWS SCIENTIFICHE 2010
CN1275614C (en) Medicinal composition for apoplexy and its sequel and its preparation
Wang et al. Effect of ear acupuncture plus injection at Zusanli (ST 36) on shoulder pain and cytokines after gynecologic laparoscopic surgery

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07720817

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07720817

Country of ref document: EP

Kind code of ref document: A1